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ABSTRACT 
 
Characterization and Safety of Clays as Potential Dietary Supplements to Prevent 
Aflatoxicosis. (May 2011) 
Alicia Guadalupe Marroquin-Cardona, B.V.M.Z., Universidad Autónoma de Nuevo 
León; M.V.Sc., Universidad Autónoma de Nuevo León 
Chair of Advisory Committee: Dr. Timothy D. Phillips  
 
 Aflatoxins are toxic metabolites produced by Aspergillus flavus and A. 
parasiticus fungi. Aflatoxin B1 (AFB1) is the most toxic and is a potent carcinogen with 
antinutritional and immunosuppressive effects. Several natural outbreaks of poisoning 
have been reported in both animals and humans, with fatal consequences in some of the 
cases. Inclusion of clay minerals in the diet is a promising strategy to reduce the 
bioavailability of aflatoxins from contaminated foods. Several clay-based products are 
currently sold as “mycotoxin binders” for addition in feeds, many of them lacking of 
detailed efficacy and safety data. Similarly, clays intended for human consumption in 
different countries also lack of safety studies, and for most of them the mineral 
composition is unknown. Earlier studies in our laboratory have shown that NovaSil clay 
(NS), a Ca-bentonite, is able to reduce the adverse effects associated with aflatoxin 
exposure in different animal species and recent human trials have confirmed its efficacy 
and safety. Most clays are derived from naturally-occurring deposits and batch-to-batch 
variations in composition, particle size, non-framework trace metal content and dioxin 
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levels are expected. Therefore, objectives in this research were to determine the mineral 
composition, aflatoxin binding capacity and potential safety of “mycotoxin binders” and 
edible clays for humans, and to investigate the mineral characteristics and safety of two 
potential aflatoxin adsorbents, a refined clay with more uniform particle size (UPSN) 
and a sodium bentonite (Na-BENT). Both clays have low dioxin/furans and heavy 
metals levels. According to mineralogical analysis, most of the “binders” contained 
montmorillonite but the sorption capacities for AF varied. Most of the edible clays for 
humans contained kaolinite, mica and quartz, and they had low sorption capacities for 
aflatoxin. UPSN and Na-BENT had similar mineral characteristics and high sorption 
capacities for aflatoxin. After a 3-month rodent study using Sprague Dawley rats, no 
overall toxicity of was observed for either clay. No changes were observed for most of 
the blood and serum biochemical parameters. Important findings included the increased 
serum Na, Ca, vitamin E and Na/K ratio and the reduction of serum K and Zn (in males) 
due to ingestion of the bentonites. Nonetheless, all parameters fell within the normal 
ranges reported for rats less than 6 months old and no trends of dose dependency were 
observed. We conclude that ingestion of low levels of bentonites does not present a 
health risk.     
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I. INTRODUCTION 
 
1.1 Aflatoxins 
 Aflatoxins (AFs) are harmful by-products of mold growth that are potentially 
fatal to humans and animals (CAST 2003). AFs are produced by the common fungi 
Aspergillus flavus and A. parasiticus; they are heat stable and resistant to a wide variety 
of food processing methods (CAST 2003). AFs were first identified in the United 
Kingdom in 1961, where highly contaminated animal feed was responsible for the deaths 
of 100 000 turkeys (Sargeant et al. 1961). Staple foods that are highly susceptible to 
aflatoxin (AF) contamination include maize, peanuts (Phillips et al. 2006), cottonseed 
and tree nuts (IARC 2002). There are four major AFs: aflatoxin B1 (AFB1), aflatoxin B2 
(AFB2), aflatoxin G1 (AFG1) and aflatoxin G2 (AFG2) that occur as direct contaminants 
of foods and feeds (Figure 1). Additionally, an important metabolic product, aflatoxin 
M1 (AFM1), is commonly found in milk of animals consuming AFB1-contaminated diets 
(Figure 1). This metabolite is considered a group 2B carcinogen and is of particular 
importance due to the high consumption of milk and milk derived products by infants. 
1.1.1 Chemical and physical properties of aflatoxins 
AFs are colorless to pale-yellow crystals that intensely fluoresce under ultraviolet 
light. AFB1 and AFB2 emit blue fluorescence and AFG1 and AFG2 emit green or green–
blue fluorescence, while AFM1 emits blue–violet fluorescence (Castegnaro et al. 1980; 
 
____________ 
This dissertation follows the style of Food Additives and Contaminants. 
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Hartley et al. 1963; O‟Neil et al. 2001). Melting points of AFs range from 237 to 299 °C. 
They are slightly soluble in water (10–30 μg mL-1); insoluble in non-polar solvents; 
soluble in moderately polar organic solvents, e.g., chloroform and methanol, and 
especially dimethyl sulfoxide (Cole and Cox 1981). Commonly, AFs are unstable to 
ultraviolet light in the presence of oxygen, and are particularly susceptible to extreme pH 
values (< 3 and > 10) and to oxidizing agents. AFs can be degraded by reaction with 
ammonia or sodium hypochlorite, with the lactone ring being particularly susceptible to 
alkaline hydrolysis (Castegnaro et al. 1980; 1991; O‟Neil et al. 2001). 
1.1.2 Occurrence of aflatoxins 
 AFs can be found in a variety of agricultural commodities, but is more frequently 
found in maize, peanuts, cottonseed, and tree nuts. Their occurrence is worldwide, but is 
common to find higher prevalence in tropical regions. This correlates well with the 
climate conditions that promote Aspergillus growth (Figure 2), which include drought, 
excessive rainfall and flooding. Recently, global climate change may be responsible for 
the emergence of AF problems in crops from regions that used to have low incidence of 
AF outbreaks. Under favorable pre-harvest conditions, A. flavus and A. parasiticus can 
produce AFs in developing seeds of corn, peanuts, cotton, almond, pistachio, and other 
tree nuts (Bhatnagar et al. 2002; CAST 2003). Contamination with the mold is not 
always coupled with toxin production. The production of AFs depends on many 
environmental and nutritional factors including moisture, temperature, substrate, 
aeration, pH levels, quantity of carbon and nitrogen sources, lipid content, 
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concentrations of different metal salts and specific nutrient requirements (Cary et al. 
2000; CAST 2003; Ominski et al. 1994).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AFB1: C17H12O        MW: 312.3  
 
AFB2: C17H14O6       MW: 314.3  
  
 
AFG1: C17H12O7      MW: 328.3 
 
AFG2: C17H14O7      MW: 330.3  
 
AFM1: C17H12O 7     MW: 328.3 
 
Figure 1. Molecular structures of the four major aflatoxins. AFB1, AFB2, AFG1, and 
AFG2, plus the important metabolic product AFM1.   
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Contamination with AFs can occur in preharvest as well as during storage 
depending on environmental conditions. Temperature ranges from 25-34 °C (Wilson and 
Payne 1994) and moisture levels exceeding 7% (Williams et al. 2004) are the main 
factors that influence preharvest and storage contamination. Water activity (aw) is a 
particularly important factor for contamination during storage. Values of aw ≥ 0.85 have 
been shown to result in increased contamination of susceptible crops (Wilson and Payne 
1994).  
On the other hand, AFM1, the hydroxylated metabolite of AFB1, mainly occurs in 
milk and milk derived products. As a biomarker of exposure to AFB1, the quantification 
of this metabolite in urine is well documented in humans and animals (Jolly et al. 2006). 
Figure 2. Corn artificially contaminated with Aspergillus flavus. Courtesy of Dr. Youjun 
Deng from the Soil and Crop Sciences Department at Texas A&M University.  
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From the cytochrome P450 enzymes, CYP1A2 is particularly responsible for oxidizing 
AFB1 into the AFM1 metabolite (Eaton et al. 1994; Wang et al. 1999) (Figure 3). Even 
though AFM1 is less toxic than the parent compound, it is still considered a public health 
concern. Different regulatory agencies like the Food and Drug Administration (FDA) 
and the European Food Safety Authority (EFSA) have established maximum permitted 
levels of 0.5 µg L
-1
 (FDA 2011) and 0.05 µg L
-1
 (EFSA 2004) in milk, respectively. 
EFSA has a more rigorous regulation for infant formulas, with a permitted level of 0.025 
µg L
-1 
(EFSA 2004). To comply with these requirements strict maximum allowance 
levels have been established for AFs in feed ingredients used for dairy cows; for instance 
the level of AF allowable in feed has been set to 20 µg kg
-1
 in the U.S.A. 
AFs can also co-occur with other mycotoxins. The most common and potentially 
dangerous case of co-occurrence is with fumonisin B1 (FB1). Several authors have 
documented the presence of both mycotoxins in samples of corn used for human 
consumption (Kimanya et al. 2008; Ueno et al. 1997). In a short-term carcinogenesis 
model using rat livers, Gelderblom (2002) demonstrated the cancer promoting activity of 
FB1 in AFB1-initiated hepatocytes. These synergistic toxicological and carcinogenic 
effects are of particular importance since populations at high risk of aflatoxicosis can 
also be co-exposed to fumonisin (Ueno et al. 1997).     
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Aflatoxin B1 
Aflatoxin Q1 
Aflatoxicol H1 
Aflatoxicol 
Aflatoxicol M1 
Aflatoxin M1 
Aflatoxin B2a 
endo-8, 9 epoxide 
Aflatoxin P1 
Aflatoxin B1 8, 9 dihydrodiol 
Figure 3. Biotransformation pathways for AFB1. The AFB1 exo-8,9-epoxide is the 
metabolite responsible for protein and DNA adduct formation. Adapted from Eaton et 
al. 1994.  
 exo-8, 9 epoxide 
CYP3A4 
CYP1A2 
CYP1A2 
CYP3A4 
CYP1A2 
mEH 
Glucoronide 
conjugate 
Glucoronide 
conjugate 
Protein adducts 
GSH conjugates 
DNA adducts 
7 
 
 
1.1.3 Exposure to aflatoxins 
Human exposure to AFs occurs predominantly through consumption of 
contaminated foods. In order to create a global report of exposure to this toxin, different 
countries have submitted information on the levels of exposure to AFs through foods to 
the Joint FAO/WHO Expert Committee on Food Additives (JECFA). Australia 
estimated an average intake of 0.15 ng AF per kg body weight (bw) per day (JECFA 
1998). The estimate for China was reported to range from 0 to 91 µg AFB1 kg-bw
-1
 per 
day (Chen 1997). The European Union (9 countries) provided estimates of AF intake 
ranging from 2 to 77 ng per person per day for AFB1 and from 0.4 to 6 ng per person per 
day for AFM1 (JECFA 1998). In the U.S.A., the FDA estimated intakes by using data 
from the National Compliance Program for maize, peanut and milk products. The results 
revealed an intake of 18 ng per person per day for AFB1 and 44 ng per person per day 
for AFM1. The AFM1 intakes estimated for developed countries differ markedly from 
African countries like Zimbabwe, for which theoretical maximum intake of AFM1 for a 
child was estimated to be 1.05 µg per day (JECFA 1998). In most places, AFM1 
exposure, at levels of nanograms per day, occurs mainly through consumption of AF-
contaminated milk, including mother‟s milk.  
AFs can also be absorbed through the lungs and skin (Coulombe 1994; Leeson et 
al. 1995). Respiratory tract exposure is mainly due to inhalation of AF-contaminated 
dust (Coulombe 1994). Recently, in utero exposure to AFs has been documented. 
Studies in The Gambia have shown AF-albumin adducts in maternal, cord,
 
and infant 
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(<1 year old) blood, demonstrating the importance of this source of exposure and its 
association with growth faltering (Turner et al. 2007). 
1.1.4 Metabolism of aflatoxins 
AFs must be bioactivated in order to exert their toxic and carcinogenic effects. 
Extensive research has focused on the biotransformation pathways for AFB1, since it is 
the most prevalent and carcinogenic of the AFs (Figure 3). AFB1 metabolism includes 
major biochemical processes like oxidation (Essigmann et al. 1977; Groopman 1994), 
reduction (Wong and Hsieh 1978), hydroxylation (Moss and Neal 1985), and 
conjugation (Holeski et al. 1987). Before systemic distribution, AFB1 can be metabolized 
in the cell barrier of the small intestine by cytochrome P450 enzymes (CYP). 
Enterocytes are known to express high levels of CYP3A isozymes and AFB1-adduct 
formation has been documented in intestinal cells from rats and humans (Kolars et al. 
1994). After absorption through the gastrointestinal tract, AFB1 enters the liver through 
the portal vein and then distribution to most soft tissues and fat deposits can occur. 
Nevertheless, the majority of the toxins accumulate in the liver and kidneys, where most 
biotransformation occurs (Leeson et al. 1995). In the human liver, AFB1 is mainly 
metabolized by CYP3A4 and CYP1A2 isozymes, leading to the formation of AFB1 exo-
8,9-epoxide and endo-8,9-epoxide (Gallagher et al. 1994; Guengerich et al. 1998). The 
formation of the exo-8,9-epoxide has been reported to be the more dominated form. 
Because of its instability, this exo-epoxide can covalently bind to DNA, commonly at the 
N-7 position of guanine (Essigman et al. 1983; Gopalakrishnan et al. 1990). This adduct 
can trigger a mutation in codon 249 of the p53 protein, specifically a G-T transversion, 
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which has been observed in hepatocarcinoma (HCC) cases from regions with high AF 
exposure (Smela et al. 2001). AFB1 can also undergo hydroxylation and demethylation, 
resulting in the formation of AFM1, AFQ1 (Ramsdell and Eaton 1990), and AFP1 (Eaton 
et al. 1994; Wong and Hsieh 1980), respectively. All these metabolites are excreted in 
urine (Coulombe 1993; Groopman et al. 1985). Additionally, lipoxygenases and 
prostaglandin H synthase may also play a significant role on AF metabolism in extra-
hepatic organs (Battista and Marnett 1985; Liu and Massey 1992). Metabolic enzymes in 
the phase I group, such as epoxide hydrolases (EH), are responsible for the conversion of 
the epoxide to dihydrodiols, while enzymes in the phase II, such as glutathione S-
transferase (GST), convert the epoxide into a more soluble form by addition of GSH 
conjugates. These products are eventually excreted in urine (Hayes et al. 1993; Wild and 
Turner 2002), although a small portion may remain in body fluids and tissues (Leeson et 
al. 1995).  
There are animal species differences in metabolisms of AFs, these differences 
account for the variations in toxicity and carcinogenic effects exerted by AFs in animals 
and humans. As an example, chickens and mice are very resistant species, while rabbits 
and ducklings are highly susceptible (Roebuck and Maxuitenko 1994) and this is likely 
due to their differences in metabolism. 
1.1.5 Toxic effects of aflatoxins 
Children and the young of all animal species are the most susceptible to the toxic 
effects of AFs. The International Agency for Research in Cancer (IARC) considers 
AFB1 and mixtures of AFs as group 1 carcinogens, while AFM1 is listed as a group 2B. 
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Signs and symptoms like jaundice, fever, ascites, vomiting and edema of the feet have 
been observed in documented cases of aflatoxicosis in India (Krishnamachari et al. 
1975). Fatalities occurred in people that may have consumed 2-6 mg AF daily over a 
month. One important observation noted in these cases, was the possible tolerance of 
women to AFs, since men appeared to be more susceptible. In Kenya, centrolobular 
necrosis of the liver was associated with the consumption of maize contaminated with 
AFB1 levels up to 12 mg kg
-1 
(Ngindu et al. 1982). AFs have also been associated with 
the development of cirrhosis (Amla et al. 1971), kwashiorkor (Hendrickse and Maxwell 
1989), and encephalitis and fatty degeneration of the viscera (Shank et al. 1971). 
Outbreaks of aflatoxicosis have been reported in different species of farm 
animals. Some important outbreaks in poultry have occurred in India (Choudary and Rao 
1982; ICRISAT 2002) where high mortality occurred. The swine industry has also been 
affected, for instance, a recent outbreak was reported in Sentinela do Sul, RS, Brazil, in 
2004. Apathy, anorexia, jaundice, dark urine, hematuria, and photosensitization were 
among clinical signs observed. Necropsy revealed generalized jaundice, an orange-
yellow liver, edema of the gall bladder wall and yellowish effusion in the abdominal and 
pericardial cavities (Zlotowski et al. 2004). Although bovines are more resistant to the 
AF effects than other species, they can also be affected by AFs. There is a report from 
1985, where more than 200 head of feedlot cattle died of aflatoxicosis after eating 
contaminated feed with levels of AFs from 96 to 1700 µg kg
-1
 (Osweler and Trampel 
1985). In that study, diagnosis was based on macroscopic findings on liver, AF levels in 
cottonseed feed products and detection of AFB1 and AFM1 in urine and liver from 
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affected calves. Cases of aflatoxicosis have also been documented in companion 
animals, such as dogs. Earlier reports include the natural outbreak of 1987 in the 
Republic of South Africa (Bastianello et al. 1987), in which 10 cases were analyzed and 
classified as acute (1 case), subacute (7 cases), and chronic (2 cases), according to the 
severity of the lesions in liver and bile ducts. Another example of aflatoxicosis in dogs 
includes the 1998 episode in Texas, with 55 confirmed deaths of dogs. The food 
implicated in that outbreak contained approximately 150 ppb AFs (Garland and Reagor 
2001). A more recent outbreak in dogs in the United States started in December 2005, in 
which 2 dogs died of acute hepatic failure after consuming a commercially available dog 
food (Stenske et al. 2006). After those cases, more dogs were reported to develop 
clinical signs of aflatoxicosis. The FDA was notified and testing confirmed 
contamination with AF. In spite of the prompt response of the FDA and veterinarians, 
approximately 100 dogs died due to the consumption of the contaminated diets. The 
amount of AF in two of the commercial diets obtained from affected owners had levels 
of AFs of 60 and 223 µg kg
-1
, respectively (Stenske et al. 2006).  
Besides the macroscopic lesions caused by AFs in different organs, AFs are also 
known to cause DNA injury (Cullen and Newberne 1994). Chromosomal aberrations 
and strand breaks, micronuclei, sister chromatid exchange, unscheduled DNA synthesis, 
and DNA-adduct formation are examples of modifications that AFB1 has been reported 
to produce (IARC 1987). Even though, the liver is the predominant target organ for 
toxicity and carcinogenicity (Miller and Wilson 1994), other organs and complete 
systems can be affected (Coulombe 1994; Kolars et al. 1994; Larsson and Tjalve 1995). 
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This appears to be the case of the immune system, for which AFs have been shown to 
have suppressive effects (Bondy and Pestka et al. 2000). Induction of thymic aplasia 
(Pier 1986), reduction of T-lymphocyte function and number, suppression of phagocytic 
activity, reduction of complement activity (Pier 1986; Reedy et al. 1987; Richard et al. 
1978) and modifications in cytokine secretion and interleukin gene expression (Han et 
al. 1999; Moon et al. 1999) are among the suppressive effects exerted by AFs in the 
immune system of different animal species. Data for the immunosuppressive effects of 
AFs in humans is scarce. However, studies by Turner et al. (2003) revealed important 
changes on immunity in Gambian children as a function of AF-albumin adducts. 
Recently, in a Ghanaian population highly exposed to AFs, Jiang et al. (2005) found 
significantly lower percentages of CD3+ and CD19+ cells expressing the CD69+ 
activation marker, than in participants with low exposure. In the same study, the 
percentages of CD8+ T cells that contained perforin or perforin and granzyme A, were 
significantly lower in participants with high AF levels. The changes in cell counts were 
significantly correlated with AF, further supporting its potential immunosuppression 
effects in humans.  
1.1.6 Carcinogenic effects of aflatoxins 
The most severe carcinogenic effect associated to AFB1 exposure is the increased 
incidence of HCC (Shupe and Sell 2004), which is one of the four most common cancers 
and the third leading cause of cancer worldwide (National Cancer Institute 2010). About 
80% of the global HCC cases occur in developing countries (Wild and Hall 2000). 
Internationally, there are geographic variations with age-specific incidence estimated to 
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be 3 and 80 per 100,000 people in North America and China, respectively (Dyer et al. 
2005), the highest rate being found in Sub-Saharan Africa, as well as East and Southeast 
Asia (Dyer et al. 2005; El-Serag 2003). The risk of hepatocarcinoma from AF 
consumption is significantly higher in individuals chronically infected with hepatitis B 
virus (Henry et al. 2002; Sun et al. 1999). Besides liver carcinogenicity, AFB1 has been 
implicated as a cause of cancer development in other organs, such as the colon (Wogan 
and Newberne et al. 1967), glandular stomach (Butler and Barnes et al. 1966) and kidney 
(Epstein et al. 1969). AFB1 is a procarcinogen that has to be metabolically activated to 
the 8,9-epoxide, which is the ultimate carcinogen (Lin et al. 1977). This epoxide can 
form the nucleic acid adduct, N7-guanine derivative 2,3-dihydro-2-N7-guanyl-3-
hydroxyaflatoxin B1 (Muench et al. 1983) (Figure 4), resulting in a DNA mutation, 
specifically a GC-TA tranversion (Foster et al. 1983). These adducts are more frequently 
found in mitochondrial DNA than in nuclear DNA, specifically in the p53 gene. This 
adduct leads to a transversion in the base pair 3 of codon 249 (Hollstein et al. 1991) 
suggesting AF exposure can enhance carcinogenicity by structural alteration of a tumor 
suppressor gene (Dragan and Pitiot 1994).  
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1.2 Strategies to control aflatoxins 
Some strategies for the reduction of AFs include; thermal inactivation, 
irradiation, solvent extraction, mechanical separation, density segregation, adsorption 
from solution, microbial inactivation, chemical inactivation, chemoprevention and clay 
therapy (Kensler et al. 1994; Phillips et al. 1994). Among the different methods, the last 
three are the most practical for feeds and foods.   
1.2.1 Chemical inactivation 
Ammoniation is the most viable chemical approach to detoxify AFs and under 
the right conditions, it can result in a significant reduction of AFs in some staple foods 
(Dollear et al. 1968). The ammoniation process, using ammonium hydroxide or gaseous 
ammonia is successfully used to reduce the AFB1 levels by more than 99% in corn, 
Figure 4. N7-guanine derivative 2,3-dihydro-2-N7-guanyl)-3-hydroxyaflatoxin B1. This 
adduct is excreted in urine and has been used as a biomarker of exposure to AFs. 
Adapted from Groopman 1994.  
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peanut-meal cakes and whole cotton seed products. The mechanism of detoxification by 
ammoniation appears to involve the hydrolysis of the lactone ring and chemical 
conversion of the parent compound AFB1 to products with lower toxicity (Figure 5). The 
first step in the reaction is reversible if the ammoniation process is not correctly done, 
however if the reaction is allowed to proceed sufficiently, the process is irreversible and 
degradation is achieved. Several countries like Mexico, France, South Africa, USA, 
Senegal, and Brazil, are already applying this method to effectively decontaminate AFs 
(Phillips et al. 1994).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NH4 +
 
  
NH3/H2O 
HO
-
/H2O 
∆ 
∆ 
AFB1 Ammonium salt of AFB1 
AFD1 MW 286 AF MW 206 
Figure 5. Ammoniation reaction of AFB1. The ammonium salt of the lactone is formed 
when AFB1 is reacted with ammonia, then it is decarboxylated by heat to form aflatoxin 
D1 and a product with molecular weight of 206 g mol
-1
. Adapted from Phillips et al. 1994.   
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Another method that has been used to inactivate AFs is ozonation. This method 
is been successfully tested in vitro (McKenzie et al. 1997) and in vivo (McKenzie et al. 
1998). In the latter study, a reduction of AFs > 95% was achieved in naturally 
contaminated corn using electrochemically generated ozone (O3) at 200 mg min
-1
. One 
day old turkeys were fed this treated corn for three weeks. Parameters measured 
included body weight, relative organs weights, serum enzyme activities, hematological 
parameters and blood chemistry. After the study period, there was no significant 
difference between the control group and the group receiving O3 treated corn, while 
significant differences were observed in the animals ingesting AF contaminated corn. 
Importantly, O3 treatment resulted in no negative effects and appeared to be safe for the 
poults while protecting them from the toxic effects of AFs. The mechanism of AFB1 
degradation by O3 involves the disruption of the C8 and C9 double bond (Figure 6), 
which is the site responsible for its carcinogenic and mutagenic effects. Contrarily to 
ammoniation, which opens the lactone ring but does not disrupt the C8 and C9 double 
bond, ozonation is a more desirable method to chemically degrade AFs that contain this 
double bond.   
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1.2.2 Chemoprotection 
Chemoprotection is known to be an effective approach for cancer prevention in 
humans (Hong et al. 1990). Possible mechanisms of action of some chemoprotectants 
used for AFs toxicity are: 1) induction of certain phase I enzymes (enhancement of 
detoxification); 2) inhibition of phase I enzymes (delay of activation); 3) induction of 
phase II enzymes (e.g. glutathione-S-transferase, GST), for enhancement of 
 
 
 
Aflatoxin B1 Aflatoxin molozonide 
Aflatoxin ozonide 
aldehydes 
ketones 
acids 
CO2 
Figure 6. Degradation of AFB1 by ozononation. The primary site of attack of ozone is at 
the C8–C9 double bond on the terminal furan. This site has been shown to be 
responsible for aflatoxin‟s mutagenicity and carcinogenicity. Adapted from McKenzie 
et al. 1998.  
O3 
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detoxification and elimination; and 4) nucleophilic trapping of reactive intermediates 
(Kensler et al. 1994). Several chemoprotectants have been shown to confer protection 
against deleterious effects of AFs in vitro and in animal studies. A few of them have 
been successfully translated to human trials. 
Oltipraz is a dithiolethione that has been shown to protect against AFB1 induced 
hepatocarcinogenesis in rodents (Kensler et al. 1992) and has also been used in human 
interventions. In an intervention trial in Qidong, People‟s Republic of China, the 
ingestion of oltipraz at high levels (500 mg per week), resulted in inhibition of phase I 
activation of AFs, while low levels (125 mg per week) increased phase II conjugation 
mechanisms, yielding higher excretion of AF-mercapturic acid (Wang et al. 1999). 
Clearly, both phenomena observed in this study can contribute to protection against the 
toxic effects of AFs in humans. In a recent double-blind, randomized, placebo-controlled 
trial performed among healthy individuals, oltipraz had no major effect on oxidative 
DNA damage, which suggests that prevention of oxidative DNA damage is not an 
important mode of action for its chemopreventive effects (Glintborg et al. 2006). This 
further supports the evidence that remediation of AF exposure through oltipraz relies on 
the chemoprotectant‟s ability to modulate phase I and II enzymes.   
1.2.3 Clay therapy in animals and humans 
The ingestion of clay by animals and humans is not a new practice. Geophagy, 
defined as the ingestion of earth or clay, has been practiced in many regions and is used 
as in traditional medicine in many African countries and China (Diamond 1999; Johns 
and Duquette 1991). 
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The use of clay-based products as enterosorbents for AFs is a frequently used 
strategy to reduce AF exposure in animals. Natural bentonites are the common sorbents 
used for this purpose. Earlier studies showed that inclusion of a calcium bentonite clay 
(NovaSil, NS) in animal feed, is able to reduce the adverse effects associated with AF 
exposure in different animal species (Phillips 1999; Phillips et al. 1988) and to decrease 
the level of an AFB1 metabolite (AFM1) in milk from lactating dairy cows and goats 
(Harvey et al. 1991; Smith et al. 1994). Equilibrium adsorption isotherms, molecular 
modeling, and in vivo studies, have been used to demonstrate that NS preferentially 
binds AFB1 in the gastrointestinal tract, thereby reducing AF systemic bioavailability 
(Phillips 1999; Phillips et al. 2002). Importantly, findings from a recent clinical 
intervention study showed that NS was effective in reducing AF protein adduct levels in 
serum, and urinary excretion of the AFM1 metabolite, in humans naturally exposed to 
AFs via contaminated foods (Afriyie-Gyawu et al. 2008b; Wang et al. 2008). 
Importantly, in this study, no nutrient interactions were observed due to NS 
consumption. Clay intervention for AFs appears to be the most culturally and 
economically plausible solution for populations that are at high risk for exposure. 
However, more research needs to be conducted in this area to characterize those 
smectites that are most favorable for AF sorption and those that are safe for prolonged 
human consumption.   
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1.3 Smectites as adsorbents for aflatoxins 
1.3.1 Smectite structure  
Bentonite is defined as a relatively impure clay rock mainly consisting of 
montmorillonite, the most abundant mineral from the smectite group, which also 
includes beidellite, nontronite, hectorite, saponite and sauconite. Smectites are 2:1 
layered minerals of high importance in soils because of their expansive properties and 
net negative interlayer charge (Figure 7). The principal source of charge in smectites is 
isomorphic substitution, but some pH dependent charge is also present. For instance, in 
montmorillonite, the substitution of Mg
+2
 for Al
+3
 in the octahedral layer is what 
produces the layer charge. Smectites are mainly found in the clay fraction of soils 
developed in temperate regions, sediments and poorly drained environments. These 
minerals are well known for their small particle size of <2µm, and their high internal 
surface area of 600-800 m
2 
g
-1
. Smectites are classified according to the type of structure 
(i.e. dioctahedral or trioctahedral), the predominant octahedral cation (i.e. Mg
+2
, Al
3+
 and 
Fe
3+
) and the location of isomorphic substitution (Reid-Soukup and Ulery 2002) (Table 
1). For industrial purposes, bentonites can be classified as sodium (Na) or calcium (Ca) 
depending on the cation found in greater amounts. Both cations have important effects 
on the behavior of smectites.  
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Table 1. Smectite classification and ideal chemical structures 
Substitution Dioctahedral Trioctahedral 
Octahedral  
 
Montmorillonite 
M
+
0.33(Si4)
IV
(Al1.67Mg0.33)
VI
O10(OH)2  
Hectorite  
M
+
0.33(Si4)
IV
(Mg2.67Li0.33)
VI
O10(OH)2 
Tetrahedral  
Beidellite  
M
+
0.33(Si3.67Al0.33)
VI
(Al2)
VI
O10(OH)2 
Saponite  
M
+
0.33(Si3.67Al0.33)
 VI
(Mg3)
VI
O10(OH)2 
 
Nontronite  
M
+
0.33(Si3.67Al0.33)
IV
(Fe
+3
)2
VI
O10(OH)2 
Sauconite  
M
+
0.33(Si3.35Al0.65)
 VI
(Zn3)
VI
O10(OH)2 
 
 
 
Figure 7. Smectite structure. The octahedral aluminum layer is depicted between the 
two silicon tetrahedral layers. Isomorphic substitution with Mg
2+
, Al
3+ 
and Fe
3+
 may 
occur in the octahedral layers. Water molecules and cations are shown in the interlayer 
zone. 
M represents one or more exchangeable metal cations and may have a value ranging from 0.2 to 0.6. Adapted from 
Reid-Soukup and Ulery 2002.  
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1.3.2 Sorption patterns and mechanisms of aflatoxin adsorption 
Four main classes of adsorption have been described for organic solutes; this 
classification is based on the nature and slope of the initial portion of the curve. 
According to the progression of the curve, these major classes are divided into 
subgroups (Figure 8). The main classes are: H, L, C and S curves (Giles et al. 1960). The 
H class is depicted by molecules that show “high affinity” for a surface, hence the name. 
This pattern is characterized by a commencement at a positive value on the 
“concentration in solid” axis. The L or “Langmuir” patterns are usually indicative of 
molecules adsorbed in a planar arrangement on the surface. C patterns are represented by 
linear curves and usually describe a “constant partition” phenomenon, in which the 
availability of adsorption sites remains constant at different solute concentrations. The S 
pattern is indicative of a cooperative adsorption effect, in which molecules that have 
been initially adsorbed (monolayer) facilitate the adsorption of more molecules 
(multilayer).  
According to isothermal analysis, the adsorption of AFB1 onto smectites can be 
classified as a Langmuir 1 or 2 curve. In this pattern, the sorbent is reaching saturation or 
saturation has been reached as the concentration of the solute is increased. It has been 
reported that L type curves are commonly depicted by chemisorption mechanisms 
between adsorbates and adsorbents (Adamson 1982). An initial strong adsorption 
followed by a plateau in the isothermal plot, suggests a specific type of binding with 
subsequent saturation of that type of binding site (Grant and Phillips et al. 1998). 
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Figure 8. Classification of adsorption patterns. The patterns represent adsorption of 
organic molecules onto surfaces of adsorbents. Adapted from Giles et al. 1960.  
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Different sites of adsorption of AFB1 onto the smectite surfaces have been 
proposed and include the external surfaces, edge surfaces (Desheng et al. 2005) and 
interlayer spaces (Kannewischer et al. 2006; Phillips et al. 2002). Data supporting the 
interlayer adsorption were first presented by Grant and Phillips (1998). In that study, a 
hydrated sodium calcium aluminosilicate (HSCAS) was heated at 800° C for 1 hr to 
collapse the interlayer area, after that, isothermal analysis of AFB1 adsorption resulted in 
significant reduction of binding capacity, demonstrating the importance of the interlayer 
as an adsorption site (Figure 9). Recently, more evidence of the interlayer adsorption of 
AFB1 was offered by Kannewischer et al. (2006); by using XRD, the authors 
documented the resistance of smectite clay to collapse when previously saturated with 
AF. In this study, smectite clay was mixed with AFB1-benzene-acetonitrile solution for 
posterior heating at different temperatures, ranging from 100°C to 245°C. XRD patterns 
of these AF-saturated heated clays were recorded along with controls and the major 
finding was the AF-reacted smectites resistance to collapse at 245°C when compared to 
controls. More recently, Deng et al. (2010) verified the interlayer absorption of AFB1 
and had similar conclusions as Kannewischer. Other authors (Desheng et al. 2005) have 
shown opposite XRD evidence for interlayer absorption of AF onto montmorillonite clay 
when using different solvents such as methanol, acetone, chloroform and water. 
Nevertheless, in the Desheng‟s study, no heating treatments were done previous to 
recording the XRD patterns, and this may account for the differences observed among 
the studies.     
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 There are not only various binding sites for AFB1 sorption on montmorillonites, 
but there are also numerous proposed binding mechanisms that could be occurring at 
these respective sites. Previously, the following six mechanisms have been proposed: 
selective chemisorption, electron donor acceptor (EDA) mechanism, hydrogen bonding, 
bonding through a furan ring, ion dipole interactions and coordination between the 
exchange cations and the carbonyl groups.    
Using simulated molecular models, Phillips et al. (1995) proposed that AFB1 can 
be bound at the edges, the interlayer surfaces, and the basal surfaces of smectite by 
selective chemisorption. Evidence of selective chemisorption was collected through a 
Figure 9. Aflatoxin adsorption isotherms on intact and collapsed NovaSil clay (Ca-
montmorillonite). Collapse was achieved after heating the clay at 800°C for 1 hr.   
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series of experiments which concluded that the carbonyls from the lactone and 
cyclopentenone rings of AF would form chelates with transition metals in the clay 
surfaces (Phillips et al. 1995). They specifically suggested the formation of a 
mononuclear (bidentate) chelate with the transition metals contained in the clay.  
The electron donor mechanism was proposed later, based on experiments that 
calculated the enthalpy of adsorption. Phillips et al. (1999) documented an enthalpy 
value of -40 kJ mol
-1
 for AFB1 bound to the surfaces of montmorillonite clay. In this 
study, the authors proposed that the partially positive carbon atoms of the two carbonyl 
groups on the AF molecule shared electrons from the negative surface of the clay. 
Additionally, they observed a positive correlation between the magnitude of partial 
positive charges on the carbons C11 and C1 of the β-dicarbonyl system of planar analogs 
and derivatives of AFB1 and the strength of adsorption. The hydrogen bonding 
mechanism for AF binding to the clay, has been reported by Desheng et al. (2005). They 
proposed that formation of double hydrogen bonds between AF and the edge sites of 
montmorillonite is the main reaction mechanism of sorption. Additionally, Tenorio et al. 
(2008) proposed that epoxidation of the dihydrofuran ring may occur due to smectite-
AFB1 interactions and further suggested that this epoxidation may contribute to the 
bonding of the toxin to smectites. The chelation of AFB1 with Ca
2+
 and other cations or 
edge-site metals was also proposed by Phillips et al. (1999) as potential mechanisms for 
binding. Observations made by Tenorio-Arvide et al. (2008) using infrared analyses, 
offered important support to the idea that exchangeable cations in the interlayer can 
coordinate with the two carbons of the coumarin moiety. Recently, more specific reports 
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on AFB1 binding to smectites suggests that, according to the hydration conditions, the 
mechanisms involved can vary (Deng et al. 2010). For instance, ion-dipole interactions 
and coordination between exchangeable cations and carbonyl groups are proposed to be 
of major importance under dry conditions. However, under high moisture conditions, H-
bonding between carbonyl groups and exchangeable-cation hydration-shell water are the 
predominant forces involved.  
Clearly, some of the above mentioned mechanisms have more experimental 
evidence than others, and there might be other mechanisms that have not yet been 
investigated. Nonetheless, all of them may be occurring simultaneously which may 
account for the high capacity of smectite clays to bind AF.   
 
1.4 Research objectives 
The AF contamination of foods and feeds is a worldwide problem. Because of its 
practicality and acceptance, the addition of clay in the diets to prevent AF exposure 
represents a highly desirable strategy. There are many types of clays and confusion 
about how to select those which are most effective is an ongoing problem. More 
importantly, due to the natural origin of these clay minerals, some may contain more 
contaminants than others (e.g. heavy metals, dioxins and furans). For instance, kaolinite 
clays (which are consumed in many parts of Africa) have been associated with high 
levels of dioxins. Hence, clays intended for AF control in animals and humans must 
have sufficient studies that prove safety and efficacy. Studies in this dissertation focus 
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on the mineral characterization and safety assessments of clays with potential use as AF 
enterosorbents, and include the following specific objectives:  
 
1) to elucidate the mineral characteristics, AFB1 adsorption capacities and potential 
safety of edible clays available and marketed as AF binders for inclusion in animal 
feeds; 
 
2) to investigate the mineral composition, AF sorption capacities and potential safety of 
edible clays intended for human consumption by using mineralogical probes, adsorption 
isotherms and a hydra toxicity bioassay; 
 
3) to investigate the mineral composition and  in vitro AFB1 sorption capacity of 
Uniform Particle Size NovaSil (UPSN) and parent NovaSil clays and to assess the 
safety/toxicity of UPSN in a three month rodent study by evaluating growth rates and 
other biochemical parameters in serum and blood;  
  
4) to investigate the mineral composition and in vitro AFB1 sorption capacity of a 
sodium bentonite and to assess its safety/toxicity in a three month rodent study by 
evaluating growth rates and other biochemical parameters in serum and blood.  
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II. IN VITRO AND IN VIVO CHARACTERIZATION OF MYCOTOXIN 
BINDING ADDITIVES USED FOR ANIMAL FEEDS IN MEXICO* 
 
2. 1 Introduction 
AFB1 is the most toxic of four naturally occurring AFs (i.e., B1, B2, G1 and G2). 
It is classified as a Class A carcinogen by the US Environmental Protection Agency 
(USEPA) and a Group 1 human carcinogen by the International Agency for Research on 
Cancer (IARC 2002). Because of its common occurrence in animal feed and its potent 
hepatotoxicity and carcinogenicity, considerable research has been directed at protecting 
animals against this toxin (Grant and Phillips 1998). The use of clay-based products as 
enterosorbents for AFs is a frequently used strategy to reduce AF exposure in animals. 
Natural bentonites (e.g. montmorillonite) are the common sorbents used for this purpose.  
In pioneering studies in Texas, inclusion of calcium montmorillonite clay 
(NovaSil, NS) in animal feed has been shown to notably reduce the adverse effects 
associated with AF exposure in different animal species (Phillips et al. 1988; Phillips 
1999) and to decrease the level of an AFB1 metabolite (AFM1) in milk from lactating 
dairy cows and goats (Harvey et al. 1991; Smith et al. 1994). Equilibrium adsorption 
isotherms, molecular modeling and in vivo studies have been used to demonstrate that  
____________ 
* Parts of the data reported in this section are reprinted with permission from “In vitro 
and in vivo characterization of mycotoxin-binding additives used for animal feeds in 
Mexico” by Marroquin-Cardona A, Deng Y, Taylor JF, Hallmark CT, Johnson NM, 
Phillips TD.  Food Addit Contam: Part A. 26(5):736-743. Copyright [2009] by Taylor & 
Francis. http://www.informaworid.com/smpp/ URL: http://dx.doi.org/10.1080/0265 
2030802641872. 
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NS preferentially binds AFB1 in the gastrointestinal tract, thereby reducing its 
bioavailability to blood, liver, and other organs (Phillips 1999; Phillips et al.2002). 
Sodium bentonites have also been shown to be effective against AFs in vitro (Diaz et al. 
2002) and in vivo (Pasha et al. 2007), although earlier investigations revealed that a 1% 
inclusion rate in the diet was not enough to protect rats against liver lesions due to AF 
(Voss et al. 1993). Zeolites (Mayura et al. 1998; Lemke et al. 2001b) and organozeolites 
(Dakovic et al. 2005) have been used as AF adsorbents as well, but some studies have 
reported that these minerals do not bind AFB1 as effectively as the bentonites (Harvey et 
al. 1993). Importantly, there is evidence that clinoptilolite (a commonly used zeolite) 
was ineffective in preventing maternal and developmental toxicity of AFB1 in rats 
(Mayura et al. 1998). This could be due to the natural conformational properties of 
clinoptilolite that prevent large molecules like AFs from entering the zeolitic pores. The 
size of AFB1 is estimated to be 12.78Å, (from the hydrogen at C2 to the hydrogen at 
C8), and 10.38 Å, from oxygen at C11 to the exocyclic carbon in the O-methyl group 
(Phillips et al. 1995). The size of the pores on natural clinoptilolite can range from 4 to 
7Å (Li et al. 2005); hence, the adsorption of AFB1 could be limited to the external 
surface only. Decreased AF-binding capacities for organozeolites could also be due to 
the exchange of these materials with synthetic surfactants like 
octadecyldimethylbenzylammonium (ODMBA) (Dakovic et al. 2005) which may 
interfere with toxin/surface interactions. Low inclusion rates and easy management of 
mycotoxin-binding additives has led to the widespread acceptance of these products by 
the farm animal industry and the introduction of a variety of materials labeled as 
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mycotoxin binders for use in feed. Thus, it is important to determine the effectiveness 
and safety of these products. The objective of this research was to characterize and 
compare twelve different products that are routinely distributed in Mexico as mycotoxin-
binding additives, by means of: (1) equilibrium isothermal analyses to delineate 
sorbent/toxin surface interactions; (2) a variety of mineralogical probes; and (3) a hydra 
toxicity bioassay. 
 
2.2 Material and methods 
2.2.1 Chemicals and reagents 
AFB1 from Aspergillus flavus was purchased from Sigma Chemical Co. (St 
Louis, MO, USA); CAS No. 1162-65-8. Acetonitrile, HPLC-grade was obtained from 
Fisher Scientific; CAS No. 75-05-8. Na2CO3 (ACS grade) was acquired from Fisher 
Scientific. MgCl2 (ACS grade) was purchased from Mallinckrodt Chemicals. All of the 
adsorption experiments were performed using high-purity deionized water (18.2MΏcm). 
Tested additives included Milbond-TX
®
 (MLB) from Milwhite, Inc., Mycoad
®
 (MCA) 
from Avimex SA, Volclay FD181
®
 (VOL) from Volclay de Mexico, Fixat
®
 (FXT) from 
Süd Chemie, Toxinor
®
 (TOX) from Norel Nature, Klinsil
®
 (KLS) from HELM de 
Mexico, Mycofix Plus 3.0
®
 (MIX) from Biomin, Mexsil
®
 (MEX) from Mexsil, 
Mycosil
®
 (MYS) from Dresen, Zeotek
®
 (ZEO) and Duotek
®
 (DUO) from Nutek S.A. 
and Mycosorb™ (MSB) from Alltech. All these additives are marketed in Mexico and 
claim to bind AFs to some extent, and some further claim to have multiple mycotoxin-
binding and/or inactivation potential. These additives were compared with NovaSil™ 
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Plus (NSP) (Engelhard, Inc.), an effective AF binder that has been extensively studied 
(Mayura et al. 1998; Phillips et al. 1998; 2006). The composition of matter for each 
additive based on information provided by individual websites and/or other publications 
was reported as follows: NSP (HSCAS, Ca-montmorillonite), VOL (Na-
montmorillonite), FXT and KLS (aluminosilicates), MEX, TOX, MLB, MYC, MCA 
(Hydrated sodium calcium aluminosilicates, HSCAS), ZEO, DUO (organo-
aluminosilicates), MSB (glucomannan/ß-D-glucan containing yeast product) and MIX (a 
synergistic mixture of minerals, biological constituents, including enzymes and BBSH 
microbe, plant-derived extracts such as flavonolignans, saponins and terpenoids, and 
some algae materials). Since kaolinite, mica, silica, and clinoptilolite can be present in 
some of these products, adsorption isotherms of AFB1 were also conducted on these 
reference minerals at pH 6.5. The abovementioned reference minerals were obtained 
from the Clay Mineral Repository (Purdue University, IN, USA) and were used as 
negative controls (i.e., materials that do not effectively sorb AFB1) (Masimango et al. 
1978; Phillips et al. 1988, Mayura et al. 1998; Huwig et al. 2001).  
2.2.2 Sample characterization 
An initial physical, mineralogical, and chemical characterization was performed 
to investigate the properties of all the additives. The pre-screening consisted of the 
following procedures: (1) the determination of the swelling volume (SV); (2) powder 
mount X-ray diffraction analysis (XRD); (3) fractionation in aqueous suspension; and 
(4) measurement of pH. The determination of SV was used as a general indicator of the 
swelling properties of the additives. Swelling (to various extents) is a required 
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characteristic of smectites. The SV, an adaptation of the coefficient of linear 
extensibility (COLE) (US Department of Agriculture, Natural Resources Conservation 
Service 2007), was examined by adding 5 cm
3
 of each additive to a 25 ml graduated 
cylinder followed by adding distilled water to a total volume of 25 ml. Each mixture was 
shaken vigorously to ensure thorough wetting, and the suspension was left to stand for 
24 h at room temperature. After 24 h, the expanded volume of settled product was 
measured, and SV was calculated based on the ratio of (volume after hydration) to 
(volume before hydration) minus one. Since the swelling properties of some organic 
materials can mimic the swelling properties of smectites, the SV values for MSB and 
MIX were not determined due to the biological composition of MSB (i.e. yeast cell 
walls) and the mixed nature of MIX (i.e. algae, plants, and bacteria).  
XRD powder mount analysis was made to evaluate the presence of smectite 
(montmorillonite) in the additives. Random powder mounts were prepared for the whole 
product of each additive. A random sample (approximately 300 mg) for each additive 
was placed in a standard rectangular aluminum plate holder (about 2 mm thick) with a 
rectangular cavity in which the sample was gently packed. All the additives were passed 
through a 140 mesh (105 mm) sieve to prevent interference due to differences in particle 
size. The presence of organic matter in the additives can interfere with the detection of 
mineral clays in the powder mounts due to aggregation effects or dilution. For that 
reason, the definite evidence of smectite presence was determined in the clay fraction 
following Mg
2+
 saturation in most of the additives, except MSB. Carbonate and organic 
matter in MEX and MIX were destroyed in order to minimize the aggregation problems. 
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The X-ray diffractograms were recorded with CuKα-radiation on a Phillips X-ray 
diffractometer equipped with a graphite monochromator and theta-compensation slit. 
The pattern was measured in 0.05°2θ intervals from 2 to 32°2θ. The particle size 
distribution in the additives was determined using an automatic fractionator. The 
percentage of particles with diameter > 0.05 mm (sand), 0.05–0.002 mm (silt), and ≤ 
0.002mm (clay), as reported by the U.S. Department of Agriculture, Natural Resources 
Conservation Service (2007), was calculated based upon the weight of each fraction 
from an initial amount of 30 g of air dried sample. The samples were then dried in an 
oven at 105°C to adjust for moisture content. Briefly, the procedure consisted of placing 
the sample into one 400 ml glass bottle filled with 30 ml of 5% NaCO3 and 250 ml of 
deionized water. The bottles were placed in a reciprocating shaker and shaken at 120 
cycles per min overnight at room temperature. Once the shaking process was complete, 
the samples were passed through a 300 mesh (53 µm) sieve to separate the sand 
particles. The sieved suspension containing the silt and clay fraction was collected into a 
polypropylene cylinder and placed on the fractionator to run the following program 
consisting of seven cycles: distilled water addition; 5 min for mixing and stirring; and 8 
h for settling. After each settling step, the suspension containing the clay fraction was 
siphoned automatically and saved in plastic containers. The sediment in the cylinders 
(silt fraction) was collected at the end of the fractionation process. In order to remove 
possible remaining clay and silt particles, the sand and silt fractions were rinsed with 
distilled water several times until the water was clear and then dried in a 105°C oven 
overnight. The clay fraction collected in 20 liter containers was flocculated by additions 
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of 1N MgCl2. Following flocculation, the supernatant was siphoned off and clays were 
concentrated by centrifugation. The amount of clay was calculated by subtraction of the 
sand and silt weights after drying from the total sample weight. The pH of each additive 
was measured by adding 4 g per sample into a beaker with 200 ml of deionized water. 
The suspension was stirred for 10 min, and the pH was measured with a pH meter 
according to the procedure described in the US Pharmacopeia for pH measurement of 
bentonite samples (U.S. Pharmacopoeia 2005). 
2.2.3 Aflatoxin adsorption analyses 
Isotherms were performed as previously described (Grant and Phillips 1998). A 
stock solution of AFB1 was prepared by dissolving pure crystals (5 mg) in acetonitrile (1 
ml) and then injecting a volume from the previous dissolved AFB1 (approximately 0.16 
ml) into 100 ml of purified water to yield a solution concentration of 8 mg ml
-1
. The 
concentration was further verified by measuring the absorbance at 362 nm on a 
Shimadzu scanning UV-visible spectrophotometer, Model 1601PC. Isothermal analyses 
for each additive were conducted at pH values of 2 and 6.5 to simulate stomach and 
small intestine pH conditions, respectively. The pH of the solutions used was adjusted 
with concentrated hydrochloric acid (HCl) and 1M sodium hydroxide (NaOH). Briefly, 
an isotherm consisted of eleven concentrations of AFB1 (0.4, 0.8, 1.2, 2.4, 3.6, 4, 4.8, 
5.6, 6.4, 7.2 and 8 mg ml
-1
) mixed with 0.1 mg of each additive in a total volume of 5 ml 
in 16 x 125 mm borosilicate glass tubes. Three replicates were used for each solute 
concentration. A suspension of each additive was prepared by weighing 100 mg into a 
50 ml Erlenmeyer flask and adding 50 ml of water to yield a concentration of 2 mg ml
-1
. 
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The suspension was mixed to ensure slurry homogeneity. From this suspension, 
50 ml (0.1 mg of additive) were added to each of the dilution tubes and the suspensions 
were vigorously stirred during the addition of the additive. Along with the dilution tubes, 
there were three controls consisting of 5 ml of water, 5 ml of AFB1 stock solution and 5 
ml of water with 0.1 mg of additive. The samples and controls were capped and placed 
on a shaker at 1000 rpm for 2 h in an incubator at 25°C. After shaking, the samples were 
centrifuged at 2000 rpm for 20 min. The supernatant was measured for absorbance at 
362 nm. Isotherms for negative controls (kaolinite, mica, colloidal silica and 
clinoptilolite) were run at pH 6.5 following the same procedure as for the additives.  
In order to compare the binding properties of the clay fraction with sand and silt 
fractions, an additional single-concentration adsorption analysis of AFB1 at pH 6.5 was 
performed with the sand, silt and clay fractions from the additives that exhibited the 
highest AFB1 sorption capacities based on the isotherms. The analysis consisted of 
triplicate aliquots of AFB1 (8 µg ml
-1
) in 5 ml reaction vials plus controls. The addition 
of sorbent, incubation time and the UV absorbance measurements were the same as in 
the isotherm procedures. The presence of smectite in the sand and silt fractions was also 
evaluated by XRD.  
2.2.4 Data calculation, curve fitting and statistics  
The UV adsorption data were used to calculate the amount of AFB1 left in 
solution at equilibrium (Cw) and the amount adsorbed to the additive (q) using the 
software Table Curve 2D v.2 and an Excel program developed in our laboratory to fit the 
data to the standard Langmuir-derived isotherm equation:                .  q = Qmax [KdCw/(1 + KdCw)]  
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The binding capacity (Qmax) and the distribution constant (Kd) were determined 
for each additive as previously described (Grant and Phillips 1998). SPSS 14.0 software 
was used to calculate the Pearson‟s correlation coefficient for the data obtained from the 
parameters measured in the pre-screening analysis and from the isotherms. Data were 
first verified for normal distribution and the absence of outliers as required for this 
model.  
2.2.5 X-ray diffractograms of Mg
2+
saturated samples 
In order to confirm the presence of smectite in the additives, three ceramic tile 
slides of Mg
2+
 saturated clay fractions were prepared by vacuum for XRD analyses. 
Three treatments were performed with the slides: (1) clay treated with 10% ethylene 
glycol (EG), (2) heating at 350°C, and (3) heating at 550°C. For the second and third 
treatments, the tiles were allowed to air dry for 24 h before heating. When treated with 
EG, smectite d-space increased from approximately 14Å to 18Å. When heated at 300 
and 550°C, the smectite 14Å d-space collapses to ~10Å. X-ray diffractograms were 
taken for each treatment in the same way as for the powder mounts. Additionally, a 
pattern was taken with the air-dry clays without any treatment. 
2.2.6 Hydra toxicity bioassay 
Adult Hydra vulgaris have been reported to be a sensitive in vivo indicator of 
toxicity for environmental and food-borne chemicals (Mayura et al. 1991; McKenzie et 
al. 1997; Ottinger et al. 1999; Huebner et al. 2000). Previous work in our laboratory has 
reported the use of hydra as a very sensitive method to evaluate toxicity of clay minerals 
and other sorbents (i.e. organoclays) (Afriyie-Gyawu et al. 2005); and contamination 
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with various priority toxic metals (other than the framework metals) have been shown to 
be toxic to adult hydra (Karntanut and Pascoe 2002), thus, we have utilized the hydra 
bioassay as an initial indicator of safety for these materials. Maintenance and feeding of 
hydra were carried out according to methods previously described (Mayura et al. 1991; 
Huebner et al. 2000; Ake et al. 2001). Hydra were not fed for 24 h before initiating the 
experiments. The assay was performed by exposing the hydra to three different 
concentrations of each additive. The concentrations (0.1%, 0.3% and 0.5%) were based 
on the inclusion rates for animal feed recommended by the additive‟s manufacturers. 
Each Pyrex
®
 60 x 15 mm test dish contained three normal healthy adult hydra in 4 ml of 
medium containing 1mM CaCl2 dihydrate, and 0.458mM TES (N-tris(hydroxymethyl)-
methyl-2-aminoethanesulfonic acid, sodium salt) buffer (adjusted to pH 7). The dishes 
were maintained at 18°C. Hydra were examined for signs of toxicity at 0, 4, 20, 28, 44, 
68 and 92 h. The toxic endpoint was determined by the „tulip‟ or „disintegration‟ stage of 
the hydra. In each test, experimental treatments were compared with untreated and 
solvent controls. 
 
2.3 Results  
2.3.1 Sample characterization 
The twelve additives showed a large range of SV from zero to greater than 4 
(Table 2). MEX showed a value of zero. In contrast, VOL had a value slightly greater 
than 4 due to its strong swelling nature upon hydration. The remaining additives had SV 
values between 0.28 and 2.92. According to the X-ray diffractograms of the powder 
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mounts, most of the additives except for MSB, DUO, MEX and MIX showed evidence 
of possible smectite presence (Figure 10). After carbonate and organic matter removal, 
powder mounts of MIX showed evidence of poorly crystallized aluminosilicates and 
quartz, while MEX confirmed previous results (no smectite evidence). Most of the 
additives except MSB showed quartz peaks, and interestingly, the additive DUO showed 
a peak compatible for clinoptilolite. The pH values of the additives ranged from 5.4 to 
9.6. In the fractionation analysis, ZEO and DUO (known as organoclays) registered the 
highest silt and the lowest clay-sized particle content, even though they had SV values of 
0.80 and 0.68, respectively. MEX registered the highest percentage of sand-sized 
particles (46%). The lowest percentage of sand-sized particles was obtained for MCA 
(6%), and this additive showed favorable sorption characteristics based on isothermal 
analysis (see below). The same trend was observed for VOL which had the highest clay 
percentage (51%) and a favorable sorption pattern. The rest of the additives ranged from 
4 to 47% clay content. According to the XRD the high percentage of clay-sized particles 
observed for MSB (60%) was mainly composed of organic matter. However, some XRD 
peaks observed for this additive were compatible with calcite mineral (Figure 10A). A 
similar phenomenon of organic matter in the clay fraction was also observed for MIX.   
  
 
4
0
 
 
Table 2. Physical and chemical characteristics of clay additives used in animal feeds 
 Notes: Smectite presence was determined by both X-ray diffractograms with Mg
2+ (air dry, heated at 300°C and 550°C) and ethylene glycol treatments. Qmax, Kd and 
r2 values were from pH 6.5 isotherms. Color classification from Munsell® soil color charts. SV: Swelling Volume; NA: not applicable; +: Positive for smectite; -: 
Negative for smectite; G: Gray; Y: Yellow.  
4
0 
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Figure 10. A) Powder mounts X-ray diffractograms of representative additives from Mexico. Specific patterns of a smectite 
containing additive (ZEO) and 4 potential additives without smectite (DUO, MIX, MEX and MSB) are shown. B) Mg
2+
 
saturated clay samples confirmed the smectite containing additive (ZEO) and the 3 potential samples without smectite (DUO, 
MIX, MEX). MSB was not included in Figure B due to difficulties preparing an oriented sample because of its mainly organic 
composition. Arrows display the mineral identification of the peaks 
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2.3.2 Isothermal and single-concentration AFB1 adsorption analyses  
Computer-generated equilibrium isotherms were extrapolated from additives data 
and fit to the Langmuir model (based on r
2
 values and randomness of the residuals). The 
parameters of Qmax (mol AFB1 kg
-1
 additive) and Kd were estimated to delineate the 
maximum sorption to the surface and the affinity of the sorption interaction. Major 
differences in AFB1 binding were observed among the additives at pH 2.0, with just five 
additives fitting the Langmuir model, i.e., NSP, MCA, VOL, MLB and MIX. The 
remaining products did not fit the Langmuir model; instead, they showed evidence of a 
constant (non-saturable) partition trend (Figure 2). In contrast, at pH 6.5, L-shaped curve 
characteristics of the isotherms were observed for many of the additives (Figure 11) with 
some variation in the r
2
 values. MSB and ZEO did not fit the Langmuir model at pH 
values of 2.0 or 6.5. The most effective binding additives for AF at both pH values were 
NSP, MLB, MCA and VOL. The highest Qmax value was obtained for NSP (Qmax= 0.4 
mol AFB1 kg
-1
) at pH values of 2.0 and 6.5. In order to directly compare the additives, 
all adsorption isotherms were force-fitted to the Langmuir equation obtaining Qmax and 
Kd values regardless of the shape or fit of the curve (Table 2). By doing so, the lowest 
value was obtained for MSB (Qmax = 0.009 and 0.015 mol AFB1 kg
-1
) at pH values of 2.0 
and 6.5, respectively. Both organoclays (ZEO and DUO) showed low AF-binding 
capacities. In studies comparing NSP (Ca-montmorillonite) with the negative controls, it 
was confirmed that the active ingredient for AFB1 binding is smectite clay (Figure 12). 
In the single-concentration adsorption analysis, NSP showed the highest percentage of 
AFB1 binding in the bulk material, the sand, silt and the clay fractions followed by MLB 
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and MCA. Other additives showed variable sorption percentages in the different 
fractions (Figure 13). All of the additives were processed under the same standard 
protocols that are used in mineralogy studies to separate the fractions of soil samples. 
XRD methodology is capable of detecting very small amounts of clay minerals, and 
while the sand fraction is composed mainly of quartz, in NSP, the sand fraction 
contained considerable amounts of smectite clay (XRD data not shown). The silt fraction 
of NSP was also found to contain smectite. This suggests that smectite aggregates with 
the size of sand or silt are prevalent in this material and in some of the other additives 
(e.g. VOL and MLB). Smectite presence in the sand and silt fractions of additives may 
be attributed to a variety of causes including, lack of complete dispersion of the sample, 
or inadequate fractionation. 
2.3.3 Pearson’s correlation coefficient 
The data from these studies were shown to be normally distributed and without 
the presence of outliers before calculating Pearson‟s correlation coefficient. Significant 
correlation values at the 0.01 level were found for SV with sand [-0.859 correlation 
coefficient (CC) (p = 0.001)] and clay [0.747 CC (p = 0.008)]. Significant correlation 
values at the 0.05 level were found for Qmax with sand [-0.660 CC ( p = 0.027)] and clay 
[0.606 CC ( p = 0.048)]. The pH values were not included in the correlation analysis 
because the data for this parameter was not normally distributed. Qmax values from 
isotherms at pH 6.5 were used in the correlation analyses. 
  
 
 
 
 
 
 
 
 
 
Figure 11. AFB1 sorption isotherms on binding additives at pH 2 and pH 6.5. Each point represents the values calculated for 
AFB1 bound and left in solution for the corresponding 11 dilutions. Isotherms were performed at 25°C. Qmax is expressed as 
mol AFB1/kg of additive. 
4
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Figure 12. AFB1 sorption on smectite clay versus non-binding materials. NSP clay was 
used as positive control for binding. Non-binding minerals included kaolinite, 
clinoptilolite, mica and silica. Isotherms were performed at pH 6.5. The highest capacity 
(Qmax) for AFB1 sorption was obtained for smectite (0.4 mol AFB1 kg
-1
 sorbent). Qmax 
values of 0.0 obtained for the other minerals demonstrate their negligible sorption 
capacity for AFB1. Sorption assays were performed at 25°C. 
 
Figure 13. AFB1 binding onto bulk versus fractionated additives. Single sorption assays 
performed at pH 6.5 (25°C temperature). Percentage of AFB1 bound was calculated 
based on the amount adsorbed by the materials from a total concentration of 8 mg ml
-1
 
AFB
1
. NSP had the highest percentage of AFB1 binding in the bulk, sand and silt 
fractions. MCA and NSP registered the highest AFB1 sorption in the clay fraction. 
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2.3.4 XRD-pattern of Mg
2+
 saturated samples 
Based on the XRD-pattern from Mg
2+
 treated samples, most of the additives 
except MSB, DUO, MEX and MIX showed evidence of smectite according to XRD 
analyses. However, the amount of smectite could not be accurately quantified without 
additional chemical analysis. Mg
2+
 saturated MSB ceramic tile could not be prepared 
due to difficulties forming an oriented sample with organic clay-size materials. The only 
XRD pattern for this sample was the powder mount. Previous degradation of carbonates 
and organic matter in the clay fraction (air dry), MEX showed a pattern suggestive of 
smectite (Figure 10), however the Mg
2+
 EG treatment did not confirm the smectite 
presence and MEX was classified as an additive without smectite. Interestingly, MIX 
additive is known to contain silicate minerals (bentonite according to a personal 
communication) but evidence of smectite was not found in this material according to our 
procedures; nevertheless quartz and apparently poorly crystallized aluminosilicates were 
present in this sample. A possible reason for non-detection of smectite in MIX could be 
a low inclusion (dilution) of bentonite. 
2.3.5 Hydra toxicity bioassay 
As a well-established and sensitive in vivo indicator of toxicity, hydra were used 
to estimate the potential toxicity of these additives. In the hydra toxicity bioassay, most 
of the additives were non-toxic to hydra except for ZEO, DUO and MSB at levels of 0.3 
and 0.5% (equivalent to the common levels of inclusion in animal feed) (Figure 14). 
Importantly, organoclays were toxic to hydra (even at the 0.1% inclusion rate).  
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2.4 Discussion 
In the sample characterization, the COLE values of the additives had a wide 
range. According to traditional estimation of COLE values, samples with a value greater 
than 0.03 are considered to contain significant amounts of smectite/montmorillonite 
clays (Buol et al. 1980). In our study, we used the same parameter from the COLE value 
(0.03) to determine qualitatively if the binding additives had significant smectite content. 
The results indicated that all the additives analyzed, except MEX, possessed a detectable 
amount of smectite. It is important to mention that traditional COLE values were used to 
Figure 14. Hydra toxicity bioassay for binding additives. Dashed line represents the 
toxic endpoint (tulip stage). Each point represents the toxicity levels at different times of 
exposure. 
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describe bulk soils, not pure clays, raw materials and mixtures as seen in this study. For 
this reason, the presence of smectite was confirmed by means of XRD powder mounts 
and clay fraction analysis. According to diffraction analysis of the powder mounts, 
evidence of smectite was found in most of the additives except for MSB, DUO, MEX 
and MIX. Concerning the pH values, most of the additives had pH values greater than 
6.7. It is not uncommon to find alkaline pH values with various aluminosilicates (Garcia-
Morales et al. 2004), as well as in confirmed smectite-containing products 
(Kannewischer et al. 2006). The US Pharmacopeia has reported a pH of 9.5–10.5 for 
natural bentonites and 9.0–10.0 for pure bentonites (US Pharmacopoeia 2005). In our 
study, we found the presence of smectite in nine of the additives and (on average) they 
had pH values of 8.55; however, there were two additives that did not correlate with 
these pH values. MLB had a pH of 6.7 with confirmed smectite presence, and MEX had 
a pH of 7.5 without evidence of smectite. The low pH values observed for MYC and 
MSB could be due to the presence of biological materials other than clay minerals as 
reported by other authors in similar products (Kannewischer et al. 2006). For this reason, 
pH values cannot be definitively used as a characterization tool for smectite presence or 
for effectiveness of sorbents for AFB1 binding. 
In the fractionation analyses, samples ZEO and DUO had the lowest clay 
content; this effect can be due to the processing of these clays. Similar organoclays are 
exchanged with long chain surfactants (Lemke et al. 1998) that can aggregate clay 
minerals and prevent the action of dispersant agents used during the fractionation 
process. According to fractionation analysis, 46% of MEX was composed of sand-sized 
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particles and this additive did not effectively bind AFB1. Most likely, the sand fraction 
of complete soils is composed of quartz (SiO2) or other primary silicates (Brady and 
Weil 2002). However, sometimes clay aggregates can be found in the sand and silt 
fractions. According to XRD, most of the additives contained smectite except for MEX, 
DUO, MSB and MIX. MIX additive is known to contain mineral clays, but we did not 
find smectite evidence in this sample. This could be related to the nature of this product 
since it is been reported that, significant dilution of minerals with other materials (e.g. 
organic carbon) observed for similar additives, can have a negative influence on the 
quality of XRD patterns (Kannewischer et al. 2006). 
In the sorption analyses, the 4 best binders had Qmax values above 0.2 mol AFB1 
kg
-1
 additive. Importantly, the results obtained for glucomannan-based products like 
MSB in our study, differ from the in vitro study of Diaz et al. (2002). In that study, 
MTB-100 (a yeast cell wall based-material) at an approximate level of 1% in solution 
was reported to sorb 96.6% of 5 mg of AF, although the sorption trend was not 
determined by isothermal analysis. In recent reports, the molecular mechanism of 
binding of AFB1 to ß-D-glucans (ingredient of glucomannan products) was shown to be 
Van der Waals attractions and hydrogen bonds (Yiannikouris et al. 2006). It is well 
established that these bonding forces are reversible and depend largely on the orientation 
of the molecules. In contrast, the proposed mechanism of binding for AFB1 on interlayer 
surfaces of smectites (e.g. NSP, Ca-montmorillonite) involves chemisorption bonding 
mechanisms (Grant and Phillips 1998) that are stronger than Van der Waals forces and 
hydrogen bonding interactions. Importantly, this interlayer interaction is 
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thermodynamically favored (Grant and Phillips 1998) and has been confirmed by XRD 
in another laboratory (Kannewischer et al. 2006). 
As has been noted, the AF-binding capacities of the additives that contained 
smectite were considerably different. This disparity may be due to a variety of factors. 
For example, the smectite inclusion level in the sample may be too low for effective 
binding. In addition, a lack of purity of the materials and contamination in mixtures 
(organic materials) could be a risk for masking the effects of smectite due to clay 
aggregation problems or dilution. Finally, processing procedures to make the materials 
more lipophilic (Lemke et al. 1998) like the organoclays, may interfere with AFB1 
adsorption onto smectite. When comparing smectite with other common minerals 
potentially found in the additives, we verified that smectite is the active ingredient, and 
this conclusion has been supported by other studies (Phillips et al. 2002; Kannewischer 
et al. 2006). 
As mentioned earlier, most of the additives were safe to the hydra except the 
organoclays and MSB, these data reinforce previous studies in mice that demonstrated 
the toxicity of organoclays (Lemke et al. 2001a; Afriyie-Gyawu et al. 2005) which 
suggested leaking of quaternary amines from the interlayer of the clays. As for MSB, the 
toxic effect exerted may be due to the growth of intact yeast and microorganisms that 
have been observed in these types of products (Kannewischer et al. 2006). 
In accordance with isothermal and single-sorption analyses from these studies, 
NSP showed the best sorption characteristics for AFB1, followed by MCA, MLB and 
VOL. Since considerable amounts of clay minerals were found in the sand and silt 
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fractions of some of the additives, further work is warranted to delineate this 
phenomenon. In order to determine the relationship of particle size to binding capacity, 
AF-binding additives need to be studied on a case-by-case basis, determining potential 
contaminants versus the primary clay mineral content. Even though most of the additives 
tested showed evidence of smectite presence, the binding capacities were significantly 
different, and only four of them showed high adsorption capacities for AFB1. The best 
binding additives showed an L-shape pattern of sorption at both pH conditions, and a 
Qmax = 0.283 or 0.212 at pH values of 2.0 and 6.5, respectively. The particle size 
distribution in the additives was found to be significantly correlated with the binding 
capacity for AFB1. Again, the presence of smectite clays in the additives was responsible 
for the capacity to bind AFB1 when compared with other major clay minerals. Major 
differences in the ability of these additives to bind AFs verify the critical need for further 
research and screening of these types of products.  
Based on our work, AF-binding additives intended for animal feed must contain 
smectite (i.e., montmorillonite) clay mineral as a primary component and should be 
rigorously evaluated in vitro and in vivo. Apart from favorable thermodynamic 
characteristics of sorption and other in vitro characterization analysis, these additives 
should be challenged in vivo to evaluate their safety and efficacy under realistic 
contamination levels of AFs and other mycotoxins. Before using these additives in 
animal feed, clear evidence of their purity (free from hazardous contaminants) and their 
negligible nutrient interactions must be considered. Further investigations in the area are 
clearly warranted. Studies should focus on claims of multiple mycotoxin binding, which 
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would suggest nonselectivity and potential interference with nutrients and other critical 
feed additives.  
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III. CHARACTERIZATION AND AFLATOXIN SORPTION EVALUATION OF 
GEOPHAGIC CLAYS FOR HUMANS  
 
3.1 Introduction 
Geophagy, defined as the ingestion of earth or clay, has been practiced in many 
regions and has been used as an acceptable treatment in traditional medicine in many 
African countries and China (Johns and Duquette 1991; Diamond 1999). Geophagy is 
usually reported in pregnant women due to a variety of reasons including treatment for 
morning sickness. Nevertheless, other uses of clays as antidiarrheal medication, 
(Vermeer and Ferrell, 1985), mineral supplement, detoxifying agent from food 
contaminants (Johns and Duquette 1991) and alleviators of hunger (Keay 1993), have 
been reported. Specifically, montmorillonite clay has been reported to adsorb AFs, toxic 
byproducts from Aspergillus flavus and Aspergillus parasiticus growth (Grant and 
Phillips 1998). AFB1 is the most potent congener of AFs and it has been classified as a 
Group 1 carcinogen (IARC, 2002). The mechanism of binding of AFB1 onto the 
interlayer surfaces of montmorillonites has been supported by several in vitro 
investigations (Phillips et al. 1988, 1995; Grant and Phillips 1998; Kannewischer et al. 
2006). Recent human studies in Ghana have demonstrated the safety and efficacy of 
NovaSil (a montmorillonite rich Ca-bentonite) in reducing the bioavailability of AFs 
when given in capsules before each meal (Afriyie-Gywau et al. 2008b; Wang et al. 
2008). Ghana is located in West Africa and is included in a group of developing 
countries that are at risk of chronic exposure to AFs based on temperature and humidity 
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conditions (between the latitudes 40°N and 40°S) that lead to vulnerability of staple 
commodities for mycotoxin contamination (Williams et al. 2004).  
Edible clays for human consumption are readily available in rural and ethnic 
markets of several developing and developed countries. The mineral composition of 
these edible clays has not been completely documented; however, due to its intended 
purpose and texture, it is believed that many contain chalk (a form of limestone 
composed of calcite) and kaolinite. Although according to geological maps (Benham and 
Brown 2007) smectite is not commonly found in Ghana, some reports have shown that 
smectite can be present at low percentages (from 0-20%) (He et al. 2007). If some of the 
edible clays available in the Ghana markets have the potential to adsorb AFs, a new 
solution for the AF contamination present in regions of Ghana will be available and 
sustainability issues will be attenuated in these regions. Countries like Haiti, Kenya and 
Uganda share similarities with Ghana regarding the availability of edible clays and AF 
contamination. These countries are also located in the “risk zone‟‟ for chronic AF 
exposure which makes their edible clays worth investigation as potential strategies to 
prevent AF toxicity. An effective enterosorbent for AF not only has to protect against 
AF bioavailability but also must be a pure compound with very low levels of heavy 
metals and other soil contaminants. Thus, it is important to investigate both the 
effectiveness and safety of these materials. By using equilibrium isothermal analyses, the 
AFB1 adsorption properties of edible clays from Ghana, Uganda, Kenya and Haiti, were 
evaluated. X-ray diffraction (XRD) analysis and other mineralogical probes were used to 
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identify the mineral composition of the edible clays and a bioassay using Hydra vulgaris 
was performed to investigate their potential safety.  
 
3.2 Materials and methods 
3.2.1 Chemicals and reagents 
For all experiments, ultrapure deionized water (UP-H2O 18MΩ cm
-1
) was used. 
NovaSil Plus (NSP) clay was obtained from Engelhard Chemical Corporation (Iselin, 
NJ, USA). AFB1 from Aspergillus flavus was purchased from Sigma Aldrich. All other 
reagents used in the sample preparation steps for the mineralogical analyses were 
analytical grade.      
3.2.2 Sample preparation and evaluation 
 Edible clay samples from Ghana (70), Uganda (2), Kenya (2), Texas (3) and 
Haiti (1), were ground, passed through a 45 µm sieve and then dried at 110 °C overnight.  
Samples from Ghana were collected in the Ejura-Sekyedumase district (ESD). The 
specific origin of the clays from Ghana was traced to the Ashanti (22), Brong/Ahafo 
(17), Central (4), Greater Accra (22), Northern (2) and Western (3) regions (Figure 14). 
Specific regions for the rest of the clays were not available.  
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 An initial sample evaluation was performed to assess the presence of carbonate 
minerals, sulfides, manganese oxides and evaporites.  The presence of calcite (CaCO3) in 
the samples was qualitatively determined by using 1M hydrochloric acid (HCl). The 
presence of oxidizing/reducing components was evaluated by adding 0.5 mL of 30% 
hydrogen peroxide (H2O2) to the samples (0.5 g). The observed reaction was 
qualitatively classified on a scale from 0 to 5, with 0 as no reaction and 5 as strong 
reaction. Occurrence of evaporite minerals was qualitatively estimated by measurement 
of electrical conductivity (EC) and acetone precipitation. The pH was measured 
according to the procedure described for bentonite samples (U.S. Pharmacopeia 2005) 
with slight adaptations. Briefly, 100 µg of each sample were placed in 15 mL glass 
Figure 15. Map of Ghana and image of a representative edible clay. A) Regions from 
which samples were collected. B) Edible clay collected in one of these regions. Map was 
obtained from http://mapsof.net/ghana/static-maps/png/ghana-regions). 
A B 
1 cm 
Greater  
Accra 
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culture tubes and shaken for 10 min. After centrifugation at 2000 rpm, the supernatants 
were used to measure EC and pH sequentially.  
3.2.3 Aflatoxin adsorption analyses 
 Isothermal analyses for AFB1 adsorption were performed as previously reported 
(Marroquin-Cardona et.al, 2009). A stock solution of AFB1 was prepared by dissolving 
pure crystals in acetonitrile and then injecting a volume from the previous dissolved 
AFB1 into 100 ml of purified water to yield a solution concentration of 8 µg ml
-1
. AFB1 
concentrations were verified by measuring the absorbance at 362 nm on a Shimadzu 
scanning UV-visible spectrophotometer, Model 1800. Isothermal analyses for each 
sample were conducted in UP-water with unadjusted pH. NSP clay was used as a 
positive control for AFB1 adsorption. Data from the isothermal analyses were fitted to 
multiple isotherm equations (i.e., Langmuir, Freundlich, Langmuir-Freundlich 
combinations, Toth, and different transformations of these equations) (Giles et al. 
1974ab; Grant et al. 1998). Data were used to calculate the sorption maximum capacity 
(Qmax) and affinity (Kd) of AFB1 to the surfaces of the clays.  
3.2.4 XRD analyses 
XRD powder mounts were prepared to determine the preliminary mineral 
composition of the edible clays. The X-ray diffractograms were recorded with a Bruker 
D8 ADVANCE X-ray diffractometer using a Cu X-ray source and κα-radiation. 
Minerals in the clays were identified by using the computer software EVA (Bruker).  
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3.2.5 Hydra toxicity bioassay 
            As a preliminary safety/toxicity evaluation, a Hydra attenuata bioassay was used 
as previously reported by Marroquin-Cardona et al. (2009). Hydra were exposed to three 
different inclusion rates 0.25%, 1% and 2% w/v of 12 representative edible clays. NSP 
clay was used as positive control for safety, while a sample known to contain high levels 
of heavy metals was used as a negative control. For each sample, 10, 40 and 80 mg were 
weighed in Petri dishes and UV irradiated in a laminar flow hood for 1 hr to prevent 
bacterial growth during the study. Three healthy adult hydra were placed in a dish with 
4.0 ml of media containing 1 mM CaCl2 dihydrate and 0.458 mM TES [N-
tris(hydroxymethyl)-methyl-2-aminoethanesulfonic acid sodium salt] buffer (adjusted to 
pH 7) and were maintained at 18°C. Hydras were examined for signs of toxicity at 0, 4, 
20, 28, 44, 68 and 92 h. The toxicity response was recorded according to a scoring 
procedure previously reported (Wilby 1988). The toxic endpoint was determined by the 
„tulip‟ or „disintegration‟ stage of the hydra. 
 
3.3 Results 
3.3.1 Sample evaluation 
Most of the clays from Ghana did not react with HCl or H2O2, suggesting that the 
presence of calcite or oxidizing components and/or organic matter are negligible or 
minimally present in the samples. In contrast, the clays from Kenya showed a strong 
reaction to H2O2 (score of 5) which suggest that these clays contain high amounts of 
oxidizing/reducing components. The color or these clays was red implying high content 
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of iron oxides. Clays from Haiti, Texas and Uganda had a similar behavior as the Ghana 
clays, where no reaction to HCl and a slight reaction to H2O2 were observed. Regarding 
the pH and EC values, the clays from Ghana had pH values ranging from 4.9 to 8.2 
(average value = 6.5), while the EC values ranged from 12.7 to 641 µS cm
-1
 (average 
value = 61.8 µS cm
-1
). Similarly, the clays from Haiti, Kenya, Texas and Uganda had pH 
values ranging from 5.7 to 8.33 and EC values ranging from 10.8 to 1009 µS cm
-1
. No 
gypsum precipitation with the acetone test was observed in any of the samples from 
Ghana or the other countries.           
3.3.2 Aflatoxin adsorption analyses 
The edible clays were grouped according to the isothermal AFB1 adsorption 
pattern they portrayed. The classification included L-shape, H-shape, S-shape and C-
shape patterns as reported by Giles (1974a). Another category termed NP (non pattern) 
was created to group the samples that displayed an unspecific sorption trend. In general, 
55% of the 78 samples showed favorable patterns of adsorption for AFB1; depicting L1, 
L2 and H shape curves. From the Ghana clays, 60% of the samples had favorable 
sorption patterns (i.e. L-shape pattern), 10% of the samples had non favorable sorption 
trends (S and C-shape patterns) and 30% did not show any specific pattern (Figure 15). 
Maximum adsorption (Qmax) and affinity (Kd) values were calculated for the samples that 
fitted the Langmuir equation with r
2
 values greater than 0.80 (33 samples). Qmax values 
ranged from 0.010 to 0.08 mol kg
-1
. A sample from the Brong Ahafo Region (sample 64) 
obtained the highest Qmax (0.08 mol kg
-1
) value, while a sample from the Ashanti Region 
(sample 4) had the lowest value (0.001 mol kg
-1
).  When compared to NSP (0.40 mol kg
-
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1
), none of the Ghana clays showed similar capacity for AF binding (Figure 16). Similar 
observations were documented for the edibles clays from Kenya, Uganda, Haiti and 
Texas (Figure 17).    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16. Representative adsorption patterns observed for clays from Ghana. The 
specific pattern type (letter) is shown in the upper left corner while the sample 
identification (number) is shown in the upper right corner.     
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Figure 17. AFB1 isothermal plots of the most effective and least effective samples from 
Ghana. These plots are compared with a standard isotherm for NovaSil. The most 
effective sample from Ghana was obtained from the Brong Ahafo Region (Qmax = 0.08 
mol kg
-1
), and the least effective sample was obtained from the Ashanti Region (Qmax = 
0.00 mol kg
-1
). None was comparable with NovaSil (Qmax = 0.40 mol kg
-1
). 
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Figure 18. AFB1 isothermal adsorption plots of NSP and clays from Haiti, Kenya, Texas (“Nzu” samples) and Uganda. 
Individual plots for groups of clays are shown in order to see the specific pattern of sorption. The most effective sample for 
AFB1 sorption was a Kenya 1 (Qmax = 0.06 mol kg
-1
). Nevertheless, none of the samples were comparable with NovaSil (Qmax 
= 0.40 mol kg
-1
). 
6
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3.3.3 XRD analyses 
Most of the edible clays from Ghana showed peaks of kaolinite, muscovite, 
feldspars and quartz minerals. The clays were grouped in four groups according to the 
minerals they contained. Some of them contained albite with chemical formula 
NaAlSi3O8 and feldspars from the orthoclase group with formula KAlSi3O8. A 
representative set of XRD patterns of the Ghanaian clays is presented in Figure 18. The 
Haiti sample showed peaks of muscovite 2M1 (10.01, 4.48, 2.56 Å), kaolinite (7.11, 
2.56 Å), orthoclase feldspars (3.19, 4.02, 3.78 Å) and calcite (3.03, 2.28 Å). In this 
sample, a 14.3 Å peak was also observed suggesting that smectite, vermiculite or 
chlorite can be present (Figure 19). More research is warranted to determine the specific 
mineral identity of the 14.3 Å peak. Sample “Kenya 1” showed peaks of hematite (2.70 
and 2.56 and1.69 Å), along with anatase (3.51, 2.37 and 1.84 Å), while “Kenya 2” 
revealed peaks of hematite (2.70 and 1.70 Å), magnetite (2.51, 1.61 and 1.48 Å) and 
quartz (3.34 Å), along with a 15.04 Å peak that is common for smectite, chlorite and 
vermiculite (Figure 20). “Uganda 1” sample showed peaks of kaolinite (7.21, 3.57 and 
1.48 Å), quartz (3.34 Å) and albite high (6.47 and 3.24 Å). “Uganda 2” had peaks of 
kaolinite, quartz and alunite (2.99 and 2.28 Å) a sulfate mineral with formula 
KAl3(SO4)2(OH)6 (Figure 21). The Texas “Nzu” sample from Irving contained kaolinite 
(7.18, 4.34 and 3.57 Å), quartz, and anatase (3.51 and 2.37 Å), a titanium dioxide 
mineral, while “Nzu” from Houston and salted “Nzu” samples contained kaolinite, 
quartz and halite (NaCl) (2.82, 1.99 and 1.62 Å). XRD patterns of “Nzu” samples are 
presented in Figure 22.  
  
 
 
 
Figure 19. Representative XRD patterns of edible clays from Ghana. All samples depicted muscovite (9.9, 4.98 Å) and 
kaolinite (7.1, 3.5 Å) peaks as well as quartz (3.3 Å). Sample 38 showed peaks compatible with alunite (5.70, 2.97, 1.90, 1.74 
Å). Sample 53 showed a broad 15.2 Å peak suggestive of vermiculite, chlorite or smectite, while sample 57 had albite peaks 
(6.3, 4.0, 3.6 Å).  
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Figure 20. Powder mount XRD of clay sample from Haiti. XRD revealed evidence of vermiculite (14.33, 2.82 Å), muscovite 
2M1 (10.01, 4.48, 2.56 Å), kaolinite (7.11, 2.56 Å), orthoclase feldspars (3.19, 4.02, 3.78 Å) and calcite (3.03, 2.28 Å).  6
5 
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Figure 21. Powder mount XRD of samples from Kenya. “Kenya 1” showed peaks of hematite (2.69, 2.56 and 1.69 Å) and 
anatase (3.51, 2.37 and 1.84 Å), while “Kenya 2” revealed peaks of smectite, chlorite or vermiculite (15.04 Å), hematite (2.70 
and 1.70 Å) and magnetite (2.51, 1.61 and 1.48 Å) along with quartz (3.34 Å).  
Kenya 2 
Kenya 1 
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6 
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Figure 22. Powder mount XRD of clays from Texas. “Nzu” sample from Irving contained kaolinite 1A polytipe (7.18, 4.34 
and 3.57 Å), quartz, and anatase (3.51 and 2.38 Å); a titanium dioxide mineral. “Nzu” from Houston and salted “Nzu” 
samples contained kaolinite, quartz and halite (NaCl) (2.82, 1.99 and 1.62 Å). 
“Nzu” Irving 
Salted “Nzu” 
“Nzu” Houston 
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Figure 23. Powder mounts XRD of clays from Uganda. “Uganda 1” sample showed peaks of kaolinite 1Md polytipe (7.21, 
3.57 and 1.48 Å), quartz (3.34 Å) and albite high (6.47 and 3.24 Å) while “Uganda 2” had peaks of kaolinite, quartz and 
alunite (2.99 and 2.28 Å) a sulfate mineral with formula KAl3(SO4)2(OH)6 . 
Uganda 1 
Uganda 2 
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3.3.4 Hydra toxicity bioassay 
In the Hydra bioassay, none of the 12 representative clays from Ghana or the rest 
of the edible clays from Haiti, Kenya, Texas and Uganda including the controls exerted 
evidence of toxicity at 0.25% w/v. Just a minor “clubbed tentacle” response was 
observed in hydra when exposed to “Kenya 2” but the tulip stage used as a toxic 
endpoint was not observed at any point throughout the study.  
 
3.4 Discussion  
From the total samples, 55% had a sorption pattern fitting either an L or H 
shaped curve. Nevertheless, none of the samples had comparable Qmax and Kd values to 
NSP. This was expected according to the mineral composition of the clays, with NSP 
containing high amounts of smectite as revealed by the XRD patterns.  
Smectite is a group of minerals with 2:1 structure found in the < 2 µm fraction of 
bentonites. They are characterized by having layer charge ranging from 0.20 to 0.60 mol 
per formula unit and high CEC values commonly reported to range from 80 to 150 cmol 
kg
-1
 (Sparks 1995; Deer et al. 1978). The interlayer of smectites is expandable and 
contains water molecules and cations. This expansion makes internal surfaces available 
for ion exchange creating large surface areas that range from 600 to 800 m
2
 g
-1
 (Reid-
Soukup and Ulery 2002). Several reports showed that AF adsorption onto smectites 
mainly occurs in the interlayer surfaces (Grant and Phillips 1998; Kanewisher et al. 
2006) and it seems to be related to the charge (net negative) (Phillips et al. 1999) and 
cations found in these internal surfaces (Deng et al. 2010). The effectiveness of smectites 
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has not just been demonstrated in several animal models but also in human studies that 
verified the safety and efficacy of ingested NS clay (a montmorillonite rich Ca-
bentonite) in reducing the bioavailability of AFs (Afriyie-Gywau et al. 2008a; Wang et 
al. 2008). Bentonites have been used as anti-caking agents in feed and foods for many 
years and are considered GRAS additives by the FDA. In our study we found that those 
clays with a ~14-15 Å peak (suggestive of smectite, chlorite or vermiculite) had a higher 
percentage of L or H-shape sorption patterns for AF (79%). Further fractionation of the 
geophagic clays and analysis of the clay fraction is needed to determine the identity of 
the mineral depicting the 14-15 Å peak.     
Kaolinite, muscovite and quartz were the most prevalent minerals present in most 
of the edible clays in the present study. From the total samples, kaolinite was found in 
97% of the samples. Specifically for the Ghanaian clays, 100% of the samples had 
kaolinite. Johns and Duquette (1991b) previously reported geophagic clays for human 
use to have a mineral composition dominated by kaolinite. Kaolinite is a 1:1 
dioctahedral phyllosilicate with the ideal chemical formula of Al2Si2O5(OH)4. This 
mineral is the most abundant phyllosilicate in highly weathered tropical regions, it has 
low surface area (Murray 2000) and CEC (1-5 cmolc kg
-1
), but it is an important source 
of anion exchange (White and Dixon et al. 2002). When compared to smectites, kaolinite 
showed unfavorable sorption pattern, and almost negligible Qmax affinity and capacity 
for AF adsorption in vitro (Marroquin-Cardona et al. 2009). The low CEC and low 
reactivity of kaolinite may explain its lack of effectiveness for AF. These characteristics 
may also appear to make its consumption safe. For instance, kaolinite is recognized as 
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GRAS additive when used as an indirect human food ingredient (food packaging) (FDA-
CFR 2010) and in the past, one important use of kaolinite was as antidiarrheal 
medication or gastrointestinal adsorbent (Kaopectate) (WHO 2005). Nevertheless, its 
consumption has been implicated in exposure to dioxins. The FDA has banned the use of 
this mineral in animal feeds due to an episode that occurred in 1997, where high levels 
of dioxins were found in different animal products (FDA 1997). The source of 
contamination was traced to a kaolinite rich clay called "ball clay," which was used as an 
anti-caking agent for animal feeds. A similar incident occurred in Europe in 1999 
(SCAN 2000). The abiogenic in situ formation of dioxins in kaolinitic clays is been 
recently proposed, suggesting that this mineral may promote synthesis of dioxins under 
high temperature and pressure (Horii et al. 2008). Because of the unavailable interlayer 
space and low CEC, charge and surface area, kaolinites are ineffective adsorbents for 
AFs. Additionally, because of the potential contamination with dioxins, the ingestion of 
kaolinitic clays is not recommended until safety is proven.    
Muscovite is also a phyllosilicate; it is included in the mica group and has a 2:1 
layer structure. It consists of two silica tetrahedral sheets on either side of the octahedral 
sheet that commonly contains Al, Mg or Fe. The layers of muscovite are held together 
by cations (especially K) that occur between the layers. Since this K is strongly held and 
not readily exchanged with other cations, the term “fixed K” is used. The general 
estimated CEC for micas at pH 7 is 30 cmol kg
-1 
(Brady and Weil 2002) and they have a 
layer charge of 1 mol per formula unit (Tompson and Ukrainczyk 2002), the highest one 
in the phyllosilicate group. Micas in the soils play an important role as K suppliers for 
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plants (Tompson and Ukrainczyk 2002). In spite of the large (negative) layer charge of 
micas, the AF sorption ability of micas has been shown to be more similar to kaolinites 
than that reported for smectites (Marroquin-Cardona et al. 2009). The low CEC and 
apparent inaccessibility of mica interlayer may explain the low AF sorption capacity of 
this mineral. Due to lack of laminar structure, charge differences and low CEC or pH 
dependent exchange capacity, minerals like iron oxides, magnesium oxides, carbonates 
(e.g. calcite), feldspars, alunite and quartz are also not expected to bind AF.            
One important concern of the consumption of geophagic clays is the potential 
leaching of heavy metals from the different minerals that compose them. For instance, 
some authors (Carretero et al. 2006) have speculated the possibility of smectite 
decomposition under the acidic conditions of the stomach (pH 2), which implies 
bioavailability of the different metal components. In this regard, Alekseyev (2007) 
reported that dissolution rates of smectites under acidic conditions will depend on pH, 
temperature and degree of saturation of the solution. For instance, in mineral dissolution 
studies using FT-IR, a Wyoming montmorillonite incubated in 6M HCl at 95 °C showed 
no structural alteration after 4 hr, minimal structural alteration after 6 hr, and not 
complete dissolution even after 30 hr (Madejová et al. 1998). Under the conditions of 
acidity found in the human stomach, pH from 1.5 to 2.5 (Wildman and Medeiros 2000), 
not much dissolution of montmorillonite is expected. More importantly, the acid 
concentrations found in the stomach are low (0.1M HCl) and inconsistent, usually 
lasting only 2 or 3 hr, depending on the types of food ingested (Degen and Phillips 
1996). Some authors have discussed the possibility of K bioavailability from weathered 
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micas and feldspars in geophagic clays (Wilson 2003). For example, plagioclase 
feldspars have been shown moderate dissolution in 0.01M HCl (Shotyk and Nesbit 
1992) and in water (Huang and Kiang 1972). Importantly, leaching of Si, Al, Ca and Na 
from plagioclase feldspars in water was observed in the first 24 hr of incubation and it 
was assumed that the rapid increase of these elements was due to cation dissolution from 
broken bonds and highly strained and disordered surfaces caused by crushing (Huang 
and Kiang 1972). The gastric dissolution of other minerals like kaolinite and illite is not 
expected to occur since non swelling minerals are more resistant to HCl dissolution 
(Jozefaciuk and Bowanko 2002). Similarly, it has been reported that minerals like 
natural alunite do not dissolve in water or acids (Özdemir and Çetisli 2005).  
Some components found in edible clays are expected to dissolve. For instance, 
the solubility of calcite, a carbonate mineral with formula CaCO3, is described by an 
inverse correlation with pH levels (Doner and Grossl 2002). Hence, calcite is projected 
to act as a calcium supplement when ingested. With regard to iron oxides, the potential 
bioavailability of Fe is expected to be dependent on the nature and reactivity of the 
mineral (Wilson 2003). Usually iron oxide solubility in water follows the order 
ferrihydrate > maghemite > lepidocrocite > hematite > goethite (Schwertmann and 
Taylor 1989) and increases with decreasing pH levels (Bigham, Fitzpatrick et al. 2002). 
As a result, it is anticipated that hematite will be more stable than ferrihydrate in the 
acidic conditions of the stomach. Nevertheless, under reducing conditions, like the ones 
found in the large intestine, iron oxides may partially dissolve and Fe bioavailability 
could increase.  
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In relation to the potential safety/toxicity of these geophagic clays, no toxicity in 
the hydra bioassay was observed at 0.25% inclusion level. The apparent safety is likely 
to be associated to the mineral composition of the edible clays, since the most prevalent 
minerals (e.g. kaolinite and quartz) have low reactivities and others such as smectites 
have been used as mucosa protectors. Only a slight clubbed tentacle response was 
observed for one of the samples from Kenya. The mineralogy of this sample revealed the 
presence of iron oxides. Our observations of non-toxic effects in the hydra upon 
exposure to iron oxides are supported by other authors that used this bioassay to test the 
safety of ferrihydrite, a hydrous ferric oxyhydroxide mineral (Taylor et al. 2009).  
In summary, most of the edible clays analyzed in the present study had limited 
capacity for AF adsorption. This was strongly related to the mineral composition of the 
clays and the specific structural characteristics of the minerals.      
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IV. CHARACTERIZATION AND SAFETY OF UNIFORM PARTICLE SIZE 
NOVASIL AS A POTENTIAL AFLATOXIN ENTEROSORBENT 
 
4.1 Introduction 
Ingestion of smectite clay is a promising approach among dietary intervention 
strategies to reduce AF exposure from food and feed. AFB1 is a group 1 carcinogen 
(IARC 2002) mainly produced by Aspergillus flavus and A. parasiticus fungi that 
commonly contaminate maize and peanuts (CAST 2003). AFB1 is a potent 
hepatocarcinogen (Busby and Wogan, 1984; Lopez et al., 2002) with genotoxic (Smela 
et al. 2001), immunotoxic (Hinton et al. 2003; Turner et al. 2003) and antinutritional 
(Williams et al. 2004; Pimpukdee et al. 2004) effects. In the U.S., the action level for 
AFs in foods intended for human consumption has been set at 20 µg kg
-1
. The EU has set 
more conservative maximum values, ranging from 0.10 to 15 µg kg
-1
. These include 
explicit values for single AFB1 and total AFs, as well as specific values according to the 
commodities analyzed.  
Montmorillonite, a mineral from the smectite group, has been shown to be the 
active ingredient for AF binding (Marroquin-Cardona et al. 2009; Kannewischer et al. 
2006). The proposed mechanism of action is through the adsorption of AFs (mainly onto 
the interlayer surfaces of montmorillonite) in the gastrointestinal tract of animals and 
humans, thus reducing toxin bioavailability to the blood and organs (Phillips 1999). 
Bentonite clays, which are rich in montmorillonite, have been effectively used in dairy 
cows (Diaz et al. 2004; Harvey et al. 1991; Kutz et al. 2009), goats (Smith et al. 1994) 
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and several other animal species (Harvey et al. 1994; Ledoux et al. 1999; Marquez and 
Hernandez 1995; Phillips et al. 1990) to diminish the negative effects of AF exposure. 
Importantly, findings from a recent clinical intervention study showed that a 
montmorillonite rich Ca-bentonite (NovaSil-Plus, NS) was effective in reducing AF 
biomarkers in serum and urine with negligible nutrient interactions in humans naturally 
exposed to AFs via contaminated foods (Afriyie-Gyawu et al. 2008b; Wang et al. 2008).  
Because of their natural origin, clays may contain numerous contaminants 
including heavy metals, dioxins and furans. For instance, in 1997, the FDA banned the 
use of “ball clay”, a kaolinite rich material, in animal feed due to the high levels of 
dioxins (FDA 1997). Some bentonites contained significantly lower levels of these 
contaminants (Afriyie-Gyawu et al. 2008a); all proposed AF binders should be 
rigorously tested for the presence of heavy metals, dioxins/furans and other potentially 
hazardous substances. Uniform particle size NovaSil clay (UPSN) is a refined Ca-
bentonite that has been selected to minimize the content of particles > 100 µm. This size 
selection is essential to diminish batch to batch differences. Expected low levels of 
contaminants and a more uniform particle size make UPSN a candidate for potential use 
as an AF sorbent in humans, upon verification of its safety and efficacy. Hence, the 
objectives of this study were to investigate the mineralogy and AF sorption 
characteristics of the refined UPSN and its parent NS, and to determine the safety of 
UPSN ingestion in a 3-month rodent study.  
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4.2 Materials and methods 
4.2.1 Chemicals and samples 
  For all experiments, ultrapure deionized water (DI-H2O 18MΩ cm
-1
) was used. 
All reagents used in the sample preparation for mineralogical analyses were analytical 
grade. AFB1 from Aspergillus flavus was purchased from Sigma Aldrich. UPSN clay 
was obtained from Texas Enterosorbents, Inc. (Bastrop, TX), and NS was obtained from 
Engelhard Chemical Corporation (Iselin, NJ). Levels of chlorinated dibenzo-p-
dioxins/furans (CDDs/CDFs) in UPSN clay were measured by Columbia Analytical 
Services, Inc. (Houston, TX). Procedures followed the U.S. Environmental Protection 
Agency (USEPA) methods for sample preparation, clean-up and analysis with high 
resolution capillary column gas chromatography/high resolution mass spectrometry 
(USEPA Method 1613B). The analysis included the 17 USEPA priority compounds. 
Dioxin and furan levels in NS were previously reported by Afriyie-Gyawu et al. (2008a). 
UPSN and NS samples were sent to Columbia Analytical Services (Kelso, Washington) 
for analysis of As, Ba, Cd, Co, Cr, Mn, Mo, Ni, Pb, Sr and Zn. USEPA method 200.8 
was used for As, Cd, Co, Cr, Mo, Ni, Pb and Zn, while method 6010B was used for Ba, 
Mn and Sr. Method 7471A was used for Hg analysis. 
4.2.2 Mineralogical analyses 
Mineralogical analyses included an initial sample evaluation to determine 
moisture content and to assess the presence of carbonate minerals, sulfides, manganese 
oxides and evaporites. Most of the mineralogical analyses were performed following 
standard procedures previously reported (Soukup et al. 2008), with minor modifications. 
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The presence of calcite (CaCO3) was checked by using 1M hydrochloric acid (HCl). 
Presence of oxidizing/reducing components was evaluated using hydrogen peroxide 
(30% H2O2). Presence of magnetic minerals was assessed by using a magnetic stir bar. 
Occurrence of evaporite minerals was qualitatively estimated by measurement of 
electrical conductivity (EC) and acetone precipitation. For EC measurement, 10 g of 
each sample were weighed into 250 mL plastic bottles. The ratio of deionized water: 
solid used was 5:1. Samples were shaken for 30 min on a rotary shaker at room 
temperature and then centrifuged at 2000 rpm for 10 min. After centrifugation, the 
supernatants were used to measure the EC and pH sequentially. Two mL of the 
supernatants were mixed with the same volume of acetone to evaluate the presence of 
gypsum.  
Other analyses included size fractionation, X-ray diffraction (XRD), Fourier 
transform infrared (FTIR) spectroscopy, scanning electron microscopy (SEM), 
transmission electron microscopy (TEM), cation exchange capacity (CEC) and 
extractable bases determination with ammonium acetate (NH4OAc) and DI-water. The 
CEC determination was done following a slightly modified procedure reported by the 
U.S. Salinity Laboratory Staff (1969), while the extractable bases using NH4OAc were 
determined with a method described by the U.S. Soil Survey Staff (1996); both analyses 
were done by the Soil Characterization Laboratory from the Soil and Crop Sciences 
Department at Texas A&M University using a mechanically controlled variable rate 
leaching device as reported by Holmgren et al. (1977). Additionally, extractable bases 
using DI-water were determined by the Soil, Water and Forage Testing Laboratory at 
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Texas A&M University, using a saturated paste extract method based on Rhoades and 
Clark (1978). An amount of 100 g of sample was used for this analysis. For NS, most of 
the mineralogical probes were performed, except for SEM and TEM.  
Before size fractionation, carbonate-based cementing and flocculating materials 
were removed using sodium acetate buffer (pH 5). Organic matter (OM) was removed 
using 30% H2O2. Samples were then dispersed with 50 mL of pH 10 sodium carbonate 
(Na2CO3) solution. The sand fraction (> 53 µm) was separated using a 53 µm sieve. The 
clay fraction (< 2 µm) was separated from the silt fraction (2-53 μm) by centrifugation 
using pH 10 Na2CO3 as dispersant. Sand and silts weights were recorded after drying at 
105 °C overnight. Clay suspensions were flocculated with sodium chloride (NaCl) and 
then dialyzed until EC measurements were close to the values of DI-water (< 2 µS cm
-1
). 
Air dry fractionation of clays was done using an Octagon 200 sieve shaker (Endecotts). 
Percentage of particles > 100 µm, 100-45 µm and < 45 µm were calculated. 
Additionally, fractionation using water (without dispersant) was achieved using the 
hydrometer method according to Mildford (1997). This was important since the presence 
or concentrations of dispersants used for fractionation assays may not be relevant to 
explain the behavior of the clays in vivo.  
XRD patterns were recorded on a Bruker D8 ADVANCE X-ray diffractometer. 
Sand and silt fractions were ground in a mortar, passed through a 140 mesh (105 µm) 
sieve and mounted as powder to collect the XRD patterns. Magnesium and potassium 
saturated clay suspensions were air dried on glass discs to obtain oriented films for XRD 
analysis. Mineral identification was determined using the EVA Bruker (Madison, WI) 
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computer software. Infrared patterns were recorded in a Spectrum 100 FTIR (Perkin 
Elmer, Inc.) using the diffuse reflectance infrared Fourier transform (DRIFT) method 
and the ATR method. For the DRIFT method, 0.005 g of sample was placed in a holder, 
using KBr as background material. For the ATR method, 1 mg of the clay fraction was 
mixed with 300 mg of KBr under a lamp to maintain dryness. Clay samples and KBr 
were mixed in a steel capsule for 30 seconds and then placed in a holder for reading.  
Silt samples of UPSN were examined in a JEOL 6400 scanning electron 
microscope with energy dispersive X-ray (EDS) recording capability. For TEM analysis, 
clay samples from UPSN were mounted on a holey carbon grid, and images were 
recorded on a JEOL 2010 microscope with EDS capability.  
4.2.3 AFB1 sorption analyses 
Isotherms were performed based on methods reported by Grant and Phillips 
(1998) and previously described in detail by Marroquin-Cardona et al. (2009). Isotherms 
were conducted in triplicate at pH 2 and 6.5. Computer-generated equilibrium isotherms 
were extrapolated from additive data and fit to the Langmuir model (based on r
2
-values 
and randomness of the residuals). The parameters of Qmax (mol AFB1 kg
-1
 additive) and 
Kd  were estimated to delineate the maximum sorption to the surface and the affinity of 
the sorption interaction. 
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4.2.4 Rodent study experimental design  
Authorization for the study was obtained by Texas A& M University, according 
to the animal use protocol (AUP) 2008-39. Sprague Dawley®™ (SD) rats were obtained 
from Harlan (Houston, TX). Animals in each group came from different litters to assure 
independence of samples. Four-week-old male (100-124 g) and female (75-99 g) rats 
were maintained on rodent feed 8604 Teklad Harlan (Madison, WI) meal form and water 
ad libitum. After a brief acclimation period (5 days), the rats (1 rat per cage) were 
allocated to either the control group (basal rodent diet) or one of the two treatment 
groups; 0.25% and 2% w/w inclusion of UPSN, with basal diet respectively. The 
corresponding groups consisted of 10 female and 10 male rats each. Dietary clay 
contents were based on the minimum effective dose (0.25% w/w) of NovaSil clay used 
in human studies (Afriyie-Gyawu et al. 2008b), and the highest level allowed (2% w/w) 
by the FDA as generally recognized as safe (GRAS) additive (Electronic Code of 
Federal Regulations, 2010). Animals were housed in a climate controlled environment 
(temperature 22–25°C), artificially illuminated (12 hr dark/12 hr light), and free from 
chemical contamination. Animals were inspected daily for general appearance, behavior, 
and signs of morbidity and mortality. Body weights were measured at baseline and every 
three days throughout the course of the study. Feed consumption was also recorded 
every three days. In total, body weight and feed consumption were recorded at 30 and 29 
time points, respectively. After 13 weeks, final body weights were recorded, and blood 
was drawn via cardiac puncture under isoflurane anesthesia. Following euthanasia, 
organs and tissues of interest were removed and evaluated for gross abnormalities. Wet 
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weights of liver, kidneys, heart, lungs, brain, spleen, tibia, and uterus plus ovaries were 
recorded. Growth parameters measured included initial body weight (IBW), final body 
weight (FBW), total body weight gain (TBWG), total feed consumption (TFC) and feed 
conversion efficiency (FCE).  
4.2.5 Hematological and serum biochemical analyses  
Hematology and serum biochemical parameters were analyzed by the Clinical 
Pathology Lab, Texas Veterinary Medical Diagnostics Lab (TVMDL) (College Station, 
TX). Hematological analysis of whole blood samples was conducted using an Abbott 
CELL-DYN 3700 Hematology Analyzer (Abbott Laboratories, Abbott Park, IL) and 
included hemoglobin (Hb) concentration, mean corpuscular hemoglobin (MCH), mean 
corpuscular hemoglobin concentration (MCHC), mean corpuscular volume (MCV), 
percent corpuscular volume (PCV), platelets, red blood cell (RBC) and white blood cell 
(WBC) counts. Leukocyte differential analysis was performed manually by microscopic 
examination of blood smears and included neutrophils, lymphocytes, monocytes, and 
eosinophils. Serum biochemical parameters were assessed using an automated analyzer 
Modular P (Roche Diagnostics, Indianapolis, IN) and included albumin/globulin ratio 
(A/G), albumin (ALB), alkaline phosphatase (ALP), alanine aminotransferase (ALT), 
amylase (AMYL), aspartate aminotransferase (AST), blood urea nitrogen (BUN), 
calcium (Ca), cholesterol (CHOL), creatine kinase (CK), chloride (Cl), creatinine (CRT), 
gamma glutamyl-transferase (GGT), globulins (GLOB), glucose (GLUC), potassium 
(K), sodium (Na), Na/K ratio, phosphorous (P), total bilirubin (T-BIL), and total serum 
protein (TSP).  
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4.2.6 Iron, zinc, vitamins A and E 
Serum micronutrients Fe and Zn were measured with a Hitachi 911 (Roche 
Laboratories, Indianapolis, IN) and a Perkin Elmer Analyst 100 (PerkinElmer, Shelton, 
CT), respectively. Vitamin A and E were measured by HPLC according to previously 
reported methods by Weinman et al. (1999) and Ruperez et al. (2004), respectively.  
4.2.7 Statistical analysis 
First, to investigate the weight gained over time among the absolute control and 
the two doses of UPSN, a linear mixed model was constructed with the fixed effect 
treatment, sex, and treatment*sex interaction. Time was included as a continuous 
variable and tested for interactions with treatment and sex. Differences in FBW were 
investigated with a similar model that included the fixed effect treatment and the 
covariates IBW and TFC as explanatory variables. Backward selection was done by 
removing one term at a time, starting with non-significant interactions (p > 0.05). 
A second analysis was performed to investigate differences in biochemical 
parameters, relative organ weights and selected vitamins and minerals among the 
absolute control and the two doses of UPSN for males and females separately. A linear 
or a generalized linear mixed model was constructed with the fixed effect treatment as 
the only independent variable. The MIXED and GLIMMIX procedures were used for all 
statistical analyses using SAS 9.2 with Enterprise Guide 4.1. In all these analyses, the 
effect of subject (i.e. rat) was considered as random, since all animals came from 
different litters (non relatives in each group). All post-test comparisons were adjusted by 
the method of Tukey-Kramer. Finally, due to the nature of the data, monocyte counts 
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and T-BIL were analyzed with non-parametric tests using SPSS 14.0. Data for T-BIL 
were classified in categories before analysis. Kruskal-Wallis test followed by Mann-
Whitney test for multiple comparisons were used to detect individual differences 
between groups.  
 
4.3 Results 
4.3.1 Dioxins/furans and mineral analyses 
The only dioxins/furans detected in UPSN were octachlorodibenzo-p-dioxin 
(OCDD) and heptachorodibenzo-p-dioxin (HpCDD). The average toxic equivalents 
(TEQs) for these compounds were calculated to be 0.0015 pg g
-1
. According to previous 
reports (Afriyie-Gyawu et al., 2008a), HpCDD and OCDD were the only dioxins in NS 
present above the limits of detection (LOD = 1.11 pg g
-1
 for HpCDD and 1.91 pg g
-1 
for 
OCDD). The combined toxic equivalent (TEQ) value calculated for both dioxins was 
0.0466 pg g
-1
. In general, the heavy metal analyses showed a similar profile for both 
clays (Table 3).  
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Table 3. Levels of heavy metals in Uniform Particle Size NovaSil and NovaSil 
 
 
 
 
Metal 
Conc. in UPSN    
(mg kg
-1
) 
Conc. in NS  
(mg kg
-1
) 
Amt. in 3 g 
UPSN (mg) 
Amt. in 3 g 
NS (mg) 
TDI/ PTDI 
(mg/kg
-1
 BW) 
Based on 70 
kg BW (mg) 
Reference 
TDI 
As 2.5 1.7 0.007 0.005 0.002 0.14 WHO, 1989 
Ba 72.1 77.5 0.216 0.233 0.051 3.57 NSCFS, 2004 
Cd 0.1 0.1 0.000 0.000 0.001 0.07 WHO, 1989 
Co 1.8 1.4 0.005 0.004 0.001 0.07 RIVM, 2001 
Cr 1.2 1.7 0.004 0.005 0.005 0.35 RIVM, 2001 
Hg 0.003 0.009 0.000 0.000 0.0002 0.01 JECFA, 2007 
Mn 223.0 172.0 0.669 0.516 0.030 2.10 OEHHA, 2004 
Mo 0.2 0.1 0.001 0.000 0.010 0.70 RIVM, 2001 
Ni 3.5 3.0 0.011 0.009 0.005 0.35 WHO, 1993 
Pb 12.6 10.5 0.038 0.031 0.003 0.21 JEFCA, 2000 
Sr 1150.0 1040.0 3.450 3.120 0.130 9.1 WHO, 2010 
Zn 53.8 38.0 0.160 0.114 1.000 70.0 JECFA, 1982 
Notes: TDI: Tolerable daily intake; PTDI: Proposed tolerable daily intake; RIVM: National Institute of Public Health and the Environment; NSCFS: Norwegian 
Scientific Committee for Food Safety; JECFA: Joint FAO/WHO Expert Committee on Food Additives; OEHHA: Office of Environmental Health Hazard Assessment; 
WHO: World Health Organization.   
8
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4.3.2 Mineralogical analyses 
The results for sample evaluation and other mineralogical analyses are 
summarized in Table 4. Differences were observed in moisture content, electrical 
conductivity, CEC, gypsum precipitation and percentages of the different fractions in 
both, dry and wet states. The major minerals identified in both samples were 
montmorillonite and quartz (Figure 23). A lower relative intensity of quartz was 
observed in UPSN suggesting less content of this mineral. Calcite and potassium 
feldspars (e.g. sanidine) were also observed in both samples. Quartz was the major 
mineral identified in the sand fractions of both samples; however a broad smectite peak 
was still evident in both samples, suggesting the presence of smectite aggregates. 
Similarly, smectite, along with sanidine, albite, muscovite, and quartz minerals, were 
identified in the silt fraction of both samples. 
Montmorillonite presence was confirmed in both samples after XRD analysis of 
the clay fraction exchanged with Mg and K. After treatment with Mg and glycerol, the d-
space of the most intense montmorillonite peak increased from ~15 to ~18 Å. Air dried 
samples exchanged with K showed a peak of ~12 Å. After heating at 330°C and 550°C, 
the K exchanged samples depicted a peak of ~10 Å and ~9.8 Å, respectively. This 
pattern of collapse of the major 15 Å peak was expected for montmorillonites. 
Montmorillonite was also confirmed with KBr-DRIFT and ATR. Both samples showed 
a characteristic band of montmorillonite of 3631 cm
-1
 (UPSN) and 3619 cm
-1
 (NS) in the 
ATR pattern. Similarly, KBr-DRIFT patterns displayed a confirmatory montmorillonite 
band at 3632 cm
-1
 (UPSN) and 3623 cm
-1 
(NS).  
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Table 4. Characterization of Uniform Particle Size NovaSil and NovaSil 
 
 
 
 
 
Parameter UPSN NS 
Moisture % 6.7 12.1 
pH  7.5 7.1 
EC (µS) 304.1 535.0 
HCl reaction Little Little 
H2O2 reaction ND Little 
Magnetic minerals ND Little 
Gypsum precipitation ND Evident 
Dry state fractions (%)   
     > 100µm 2 20 
    100-45µm 67 30 
     < 45µm 31 50 
Wet sate fractions (%) (water + Na2CO3 )   
     >53µm  1.0 15.0 
     2-53µm  23.0 20.0 
     <2µm  76.0 65.0 
Wet state fractions (%) (water)   
     >50 µm  0 25 
     2-50 µm  25 67 
     <2 µm  75 8 
CEC (cmol kg
-1
) 89.2 82.9 
Extractable bases (cmol kg
-1
)(NH4OAc)   
     Ca 98.4 85.8 
     Mg 8.7 9.1 
     Na 0.5 0.5 
     K 1.7 1.5 
Soluble bases (mEq L
-1
)(DI-water)*   
Ca 8.1 20.4 
Mg 0.7 1.6 
Na 0.9 1.4 
K 0.6 0.8 
Notes: * Soluble bases were measured in DI-water vacuum extracts from a paste according to Rhoades 
and Clark 1978; ND: non-detectable. 
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Figure 24. Powder mounts XRD patterns of UPSN and parent NS. Minerals identified in both samples included 
montmorillonite (15.23, 5.1, 4.48, 1.49 Å), mica (9.9, 2.5 Å), quartz (3.3 Å), calcite (3.0 Å), orthoclase feldspars (3.7 Å) and 
sanidine (3.24, 3.20 Å). Quartz relative intensities in UPSN were lower than in parent NS. 
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Additionally, bands of AlFeOH deformation (884 and 882 cm
-1
) and AlMgOH 
(842 and 845 cm
-1
) were observed for UPSN and NS, respectively. SEM findings for the 
silt fraction of UPSN confirmed the presence of feldspars and mica. Additionally, 
smectite particles were noted in the silts (Figure 25A). The main feature observed in the 
TEM images was the folding tendency of montmorillonite particles (Figure 25B). The 
particles are shown as thin films of considerable length (3-5 µm) that fold many times 
and can be described like a “veil fabric”.     
 
 
 
 
 
 
 
 
 
 
Figure 25. SEM and TEM images of smectite particles in UPSN. A) SEM image of 
smectite particle in UPSN. The particle is depicting a globular morphology with 
dimensions of ~25 µm x 15 µm, according to the scale bar.  B) TEM image of smectite 
particle displaying complex morphology of sheets and rolls. This morphology is 
commonly observed for good aflatoxin adsorbents, according to Mulder et al. (2008). 
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4.3.3 AFB1 sorption analyses 
 The parameters of Qmax and Kd were similar for both samples at both pH levels. 
Samples fitted the Langmuir model (r
2
 ≥ 0.92) and depicted the favorable AF sorption 
pattern characterized as L-shape (Figure 26). Specifically at pH 6.5, and L2-pattern was 
documented for both samples (plateau has been reached); while at pH2 the sorption 
pattern more closely resembled an L1-pattern (in process of reaching the plateau). The 
Qmax values calculated for UPSN and NS at pH 2 were 0.39 ± 0.01 and 0.40 ± 0.03 mol 
AFB1 kg
-1
, while at pH 6.5 Qmax  values were 0.44 ± 0.05 and 0.41 ± 0.02 mol AFB1 kg
-
1
, respectively. A slight higher binding capacity was noted for UPSN at pH 6.5 when 
compared to NS.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26. AFB1 adsorption onto UPSN and NS at pH 6.5 and 2. Both samples depicted 
an L-shape pattern characteristic of planar arrangement of molecules adsorbed on the 
surface. The bend on the pattern indicates that the sorbent is reaching saturation as the 
concentration of the solute is increased. The Qmax values calculated for both bentonites 
were similar at both pH levels, ranging from 0.39 to 0.44 mol AFB1 kg
-1
.   
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4.3.4 Rodent study outcomes    
No apparent adverse effects due to consumption of either dose of UPSN were 
noticed throughout the study. All rats remained healthy and active without noticeable 
changes in behavior. Males gained more weight than the females (p < 0.0001), as 
expected. Gained weight across time was different in at least on of the treatment groups 
(p = 0.0099) and the effect of treatment was different between males and females (p = 
0.0007). There was no difference in weight gained in the males across all time points (a 
total of 30 time points recorded) and groups. In contrast, females in the control group 
gained more weight than the females in the 2% UPSN group by time 15 (day 43) (p = 
0.0351) and consecutively up to time 30 (day 88) (p = 0.0026), but not on time 10 (day 
28) or before. Similarly, females in the 0.25% UPSN group gained more weight than the 
females in the 2% UPSN group by time 30 (day 88) (p = 0.0362) but not on time 25 (day 
73) or before. Significant differences were observed between the control and the 
treatment groups for some of the growth parameters in the females (Table 5). TFC and 
IBW were not significant factors for explaining the differences in FBW of the females.  
4.3.5 Hematological and serum biochemistry analyses  
No statistically significant differences were observed between the control and the 
UPSN groups for most of the biochemical parameters measured (Tables 6 and 7). 
Nevertheless, some significant differences were registered in at least one of the treatment 
groups, for either females or males. Importantly, most of the parameters measured in this 
study fell between the normal ranges reported for control animals (< 6 months old) in 
several studies and did not show patterns of dose dependency. 
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Table 5. Growth parameters of SD rats receiving dietary UPSN at 0.25 and 2% for 13 weeks 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Group Control UPSN 0.25% UPSN 2% 
Females  
   
FBW (g) 243.85 ± 13.49 242.41 ± 10.29
a
 231.42 ± 6.67
*b
 
FCE 13.24 ± 2.74 13.60 ± 2.33
a
 16.45 ± 2.72
*b
 
IBW (g) 99.52 ± 4.75 95.88 ± 4.93 94.72 ± 3.25
*
 
TBWG (g) 144.33 ± 10.12 146.53± 9.43
a
 136.70 ± 7.23
b
 
TFC (g) 1899.17 ± 341.57 1982.55 ± 292.75 2244.73 ± 368.36 
Males  
   
FBW (g) 406.45 ± 19.99 423.65 ± 13.8 424.88 ± 13.89 
FCE 7.42 ± 0.70 7.42 ± 0.32 7.19 ± 0.25 
IBW (g) 120.87 ± 3.65 122.37 ± 4.20 124.42 ± 4.64 
TBWG (g) 285.58 ± 20.18 301.28 ± 12.95 300.46 ± 12.14 
TFC (g) 2110.08 ± 104.45
 
2233.62 ± 102.72
 
2160.43 ± 42.07
 
Notes: Means with asterisk are significantly different from the control at the 0.05 level. Means with different 
letters are significantly different between USPN treatment groups at the 0.05 level. Data are reported as mean 
values ± standard deviation. FBW: Final body weight; FCE: Feed conversion efficiency; IBW: Initial body 
weight; TBWG: Total body weight gain; TFC: Total feed consumption.  
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Table 6. Hematological parameters of SD rats receiving dietary UPSN at 0.25 and 2% for 13 weeks 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Group    
Parameter Control UPSN 0.25% UPSN 2% Normal values Reference 
Females      
Eosinophils µL-1 25.30 ± 29.91 25.30 ± 37.83 25.10 ± 35.23 ~ 196.50 ± 216.10  B 
Hb (g dL-1) 14.19 ± 0.33 13.96 ± 0.59 13.77 ± 0.34* 14.30 ± 0.83 C 
Lymphocytes µL-1 3755.10 ± 907.92  5654.00 ± 1992.89* 4497.20 ± 855.67 6880.00 ± 2630.00 B 
MCH (pg) 18.44 ± 1.70 18.33 ± 2.30 19.14 ± 1.91 19.8 ± 0.94 C 
MCHC (g dL-1) 34.43 ± 0.72 33.30 ± 1.00* 33.36 ± 0.55* 34.40 ± 0.50  B 
MCV (fL) 55.85 ± 1.76 57.72 ± 2.40 58.36 ±1.55* 57.90 ± 2.10 B 
Monocytes µL-1 0 ± 0.00 81.60 ± 70.85*a 0 ± 0.00b ~19.60 ± 58.90 B 
Neutrophils µL-1 163.70 ± 111.49 288.30 ± 373.30a 44.70 ± 62.04b 870.00 ± 660.00  B 
PCV (%) 41.24 ± 1.53 41.96 ± 2.07 41.30 ± 1.42 38.10 ± 2.43 C 
Platelets (x103) µL-1 468.20 ± 77.83 619.40 ± 224.76a 344.80 ± 85.57b 471.68 ± 38.77 A 
RBCs (x106) µL-1 7.39 ± 0.29 7.27 ± 0.29 7.08 ± 0.31 7.02 ± 0.40 B 
WBC µL-1 3944.00 ± 962.96 6049.00 ± 2267.71* 4567.00 ± 872.60 7840.00 ± 2950.00 B 
Males      
Eosinophils µL-1 134.00 ± 109.88 49.30 ± 86.83 39.60 ± 60.57 ~89.30 ± 114.80 B 
Hb (g dL-1) 14.51 ± 0.46 14.40 ± 0.36 15.05 ± 0.78 14.70 ± 1.22 C 
Lymphocytes µL-1 6265.60 ± 1994.52 6951.40 ± 1839.27 6047.30 ± 1083.73 6880.00 ± 2630.00  B 
MCH (pg) 18.78 ± 0.45 18.05 ± 0.41* 18.46 ± 0.50 19.00 ±1.09 C 
MCHC (g dL-1) 33.77 ± 0.71 32.59 ± 0.64*a 33.82 ± 0.58b 34.10 ± 0.40 B 
MCV (fl) 55.78 ± 2.25 55.49 ± 1.63 54.61 ± 1.70 59.50 ± 2.00 B 
Monocytes µL-1 18.80 ± 54.70 95.30 ± 96.04 19.10 ± 31.57 ~38.20 ± 63.80 B 
Neutrophils µL-1 819.90 ± 669.78 517.00 ± 623.21a 79.10 ± 50.89*b 870.00 ± 660.00 B 
PCV (%) 43.10 ± 1.73 44.22 ± 1.48 44.50 ± 1.96 39.90 ± 3.49 C 
Platelets (x103) µL-1 418.60 ± 133.39 692.50 ± 145.47*a 374.00 ± 81.09b 471.68 ± 38.77  A 
RBCs (x106) µL-1 7.73 ± 0.32 7.97 ± 0.31 8.15 ±0.28* 7.82 ± 0.83 C 
WBC µL-1 7238.00 ± 2462.55 7613.00 ± 2293.36 6185.00 ± 1106.74 7840.00 ± 2950.00 B 
Notes: Means with asterisk are significantly different from the control at the 0.05 level. Means with different letters are significantly 
different between UPSN treatment groups at the 0.05 level. Data are reported as mean values ± standard deviation. Hb: hemoglobin; MCH: 
mean cell hemoglobin; MCHC: mean corpuscular hemoglobin concentration; MCV: mean corpuscular volume; PCV: packed cell volume; 
RBC: red blood cell; WBC: white blood cell. References: A) Almodovar et al. 1985; B) Lillie et al. 1996; C) Woldford et al. 1986. 
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Table 7. Serum biochemical parameters of SD rats receiving dietary UPSN at 0.25 and 2% for 13 weeks 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Group  
Parameter Control UPSN 0.25% UPSN 2% Normal values Reference 
Females 
A/G Ratio 2.41 ± 0.11
 
2.18 ± 0.21* 2.41 ±0.22
 
2.13 ± 0.18 A 
ALB (g dL
-1
) 3.74 ± 0.15 3.79 ± 0.10 3.77 ± 0.13 3.41 ± 0.23 C 
ALP (U L
-1
) 58.40 ± 14.23 67.60 ± 17.10 69.20 ± 7.87 117 ± 41.7 B 
ALT (U L
-1
) 54.70 ± 9.47 51.00 ± 8.75 51.60 ± 9.77 44.00 ± 23.9 D 
AMYL (U L
-1
) 1258.40 ± 112.41 1413.50 ± 268.12 1341.70 ± 138.95 1703 ± 164.32 A 
AST (U L
-1
) 138.20 ± 42.38
 
98.40 ± 24.23* 103.40 ± 24.96
 
93.00 ± 30.3 D 
BUN (mg dL
-1
) 18.44 ± 1.70 18.33 ± 2.30 19.14 ± 1.91 21.00 ± 3.90 D 
Ca (mg/dL) 9.34 ± 0.32
 
9.80 ± 0.25*
a
 9.53 ± 0.22
b 
10.36 ± 0.32 C 
CHOL (mg dL
-1
) 86.73 ± 9.33 92.43 ± 11.80 90.35 ± 10.52 89.00 ± 23.00 D 
CK (U L
-1
) 815.11 ± 360.20
 
262.70 ± 102.96* 558.20 ± 421.90
 
210.00 ± 109 C 
Cl (mEq L
-1
) 94.50 ± 19.54 101.90 ± 1.37 101.50 ± 0.84 104.00 ± 2.40 B 
CRT (mg dL
-1
) 0.29 ± 0.03 0.30 ± 0.03 0.32 ± 0.02 0.55 ± 0.10 C 
GGT (U L
-1
) <3.0 <3.0 <3.0 <3.0 A 
GLOB (g dL
-1
) 1.55 ± 0.08
 
1.75 ± 0.16* 1.57 ± 0.14
 
1.91 ± 0.09 A 
GLUC (mg dL
-1
) 180.10 ± 15.62 192.00 ± 20.48 190.00 ± 20.79 199.80 ± 21.60 C 
K (mEq L
-1
) 5.71 ± 1.33 4.89 ± 0.32 4.68 ± 0.19* 4.76 ± 0.44 C 
Na (mEq L
-1
) 129.80 ± 25.68 140.30 ± 1.06* 141.60 ± 0.70* 142.00 ± 2.00 C 
Na/K Ratio 23.04 ± 2.99
 
28.80 ± 1.78* 30.32 ± 1.28* ~29 C 
P (mg dL
-1
) 5.56 ± 0.87 4.94 ± 0.61 5.30 ± 0.37 5.80 ± 1.10 B 
T-BIL (mg dL
-1
) 0.09 ± 0.05 0.07 ± 0.06 0.13 ± 0.02 0.30 ± 0.24 D 
TP (g dL
-1
) 5.29 ± 0.21
 
5.54 ± 0.17* 5.34 ± 0.19
 
6.17 ± 0.33 C 
Notes: Means with asterisk are significantly different from the control at the 0.05 level. Means with different letters are significantly 
different between UPSN treatment groups at the 0.05 level. Data are reported as mean values ± standard deviation. ALB: albumin; ALP: 
alkaline phosphatase; ALT: alanine aminotransferase; AMYL: amylase; AST: aspartate aminotransferase; BUN: blood urea nitrogen; 
CHOL: cholesterol; CK: creatine kinase; CTR: creatinine; GGT: gamma-glutamyl transferase; GLOB: globulin; GLUC: glucose; T-BIL: 
total bilirubin; TP: total protein. References: A) Afriyie-Gyawu et al. 2005; B) Kohn and Clifford 2002; C) Lillie et al. 1996; D) Woldford et 
al. 1986.  
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Table 7. continued 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Group  
Parameter Control UPSN 0.25% UPSN 2% Normal values Reference 
Males 
A/G Ratio 1.93 ± 0.15 1.75 ± 0.17 1.82 ± 0.10 1.37 ± 0.18 A 
ALB (g dL
-1
) 3.42 ± 0.15
 
3.67 ± 0.20*
 
3.70 ± 0.16*
 
3.40 ± 0.20 B 
ALP (U L
-1
) 79.20 ± 9.47 60.40 ± 14.35*
 
58.40 ± 8.45* 130 ± 43.7 B 
ALT (U L
-1
) 61.30 ± 19.38
 
49.20 ± 8.79
a
 40.20 ± 3.82*
b
 49.00 ± 24.1 B 
AMYL (U L
-1
) 2316.00 ± 211.13 2329.80 ± 274.48 2305.20 ± 192.53 2671.00 ± 89.00 A 
AST (U L
-1
) 116.80 ± 49.97
 
104.40 ± 31.13
a
 70.30 ± 13.42*
b
 97.00 ± 28.40 D 
BUN (mg dL
-1
) 19.41 ± 2.63 20.98 ± 2.50 20.88 ± 3.08 20.00 ± 3.20 D 
Ca (mg dL
-1
) 9.12 ±  0.39
 
9.90 ± 0.18* 9.82 ± 0.30*
 
10.48 ± 0.28 C 
CHOL (mg dL
-1
) 85.37 ± 10.16 95.70 ± 9.79
 
97.69 ± 12.03* 75.00 ± 19.80 D 
CK (U L
-1
) 432.22 ± 227.32 338.80 ± 151.83 271.60 ± 92.34 222.00 ± 109.00 C 
Cl (mEq L
-1
) 98.30 ± 2.26 100.20 ± 0.92 101.00 ± 2.30* 103.00 ± 1.90 B 
CRT (mg dL
-1
) 0.26 ± 0.03 0.29 ± 0.03 0.28 ± 0.02 0.54 ± 0.08 C 
GGT (U L
-1
) <3.0 <3.0 <3.0 <3.0 A 
GLOB (g dL
-1
) 1.78 ± 0.15
 
2.11 ± 0.14*
 
2.04 ± 0.11* 2.51 ± 0.25 A 
GLUC (mg dL
-1
) 192.70 ± 37.05 214.20 ± 39.70 192.10 ± 19.83 212.40 ± 28.8 C 
K (mEq L
-1
) 7.23 ± 0.66
 
5.11 ± 0.38*
 
5.38 ± 0.27*
 
5.30 ± 0.39 C 
Na (mEq L
-1
) 135.20 ± 2.74 140.80 ± 0.63* 142.30 ± 3.30* 142.00 ± 2.00 C 
Na/K Ratio 18.86 ± 1.74
 
27.69 ± 2.11* 26.51 ± 1.36* ~26 C 
P (mg dL
-1
) 5.92 ± 0.39 6.08 ± 0.59 6.15 ± 0.22 7.30 ± 1.50 B 
T-BIL (mg dL
-1
) 0.01 ± 0.03 0.07 ± 0.06
 
0.09 ± 0.05* 0.30 ± 0.16 D 
TP (g dL
-1
) 5.20 ± 0.25
 
5.78 ± 0.17*
 
5.74 ± 0.22*
 
5.85 ± 0.23 C 
Notes: Means with the same letter are not significantly different at the 0.05 level. Means with different letters are significantly different 
between UPSN treatment groups at the 0.05 level. Data are reported as mean values ± standard deviation. ALB: albumin; ALP: alkaline 
phosphatase; ALT: alanine aminotransferase; AMYL: amylase; AST: aspartate aminotransferase; BUN: blood urea nitrogen; CHOL: 
cholesterol; CK: creatine kinase; CTR: creatinine; GGT: gamma-glutamyl transferase; GLOB: globulin; GLUC: glucose; T-BIL: total 
bilirubin; TP: total protein. References: A) Afriyie-Gyawu et al. 2005; B) Kohn and Clifford 2002; C) Lillie et al. 1996; D) Woldford et al. 
1986.  
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4.3.6 Iron, zinc, vitamin A and E analyses  
No statistically significant differences were observed between the control and the 
treatment groups for Fe and vitamin A, in either males or females. Differences were 
observed for Zn, in both sexes of the 2.0% UPSN group when compared to the control 
(Table 8). However, Zn values were still within the ranges reported by other authors for 
28 week old control animals (Afriyie-Gyawu et al. 2005). Serum vitamin E was 
significantly increased for both sexes in the UPSN groups (Table 8). 
4.3.7 Relative organ weights  
 Isolated differences were observed in relative organ weights for both males and 
females (Table 9). However, none of the differences registered for relative organ weights 
suggested dose dependency.  
 
4.4 Discussion 
4.4.1 Mineral characteristics and AFB1 sorption analyses 
The levels of dioxin/furans in UPSN were lower than in parent NS. The Joint 
FAO/WHO Expert Committee on Food Additives (JECFA) has placed a provisional 
tolerable daily intake (PTDI) value for dioxins of ~2.3 pg WHO-TEQ kg-bw
-1
 day
-1
 
(JECFA 2001) for humans. 
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Table 8. Serum Fe, Zn, vitamin A and E of SD rats receiving dietary UPSN at 0.25 and 2% for 13 weeks 
 
 
 
 
 
 
 
 Group  
Parameter Control UPSN 0.25% UPSN 2% Normal values Reference 
Females  
Iron (µg dL-1) 254.67 ± 38.20 245.74 ± 33.98 246.47 ± 60.02 220 ± 130 B 
Zinc (µg mL-1) 1.24 ± 0.18
 
1.34 ± 0.09
a
   1.12 ± 0.10
b
 1.05 ± 0.09 A 
Vitamin A (µg L-1) 267.31 ± 27.78 275.50 ± 33.92 271.01 ± 19.11 254.10 ± 6.00 A 
Vitamin E (µg L-1) 3560.00 ± 40.00
 
9150.00 ± 1350
* 
8500.00 ± 1040.00
* 
NA  
Males 
Iron  (µg dL-1) 115.89 ± 10.92 126.87 ± 19.99 123.45 ± 16.62 152 ± 70 B 
Zinc (µg mL-1)   1.50 ± 0.09
a 
  1.51 ± 0.13
a
     1.24 ± 0.09
*b
 1.29 ± 0.04 A 
Vitamin A (µg L-1) 530.80 ± 39.44 489.50 ± 80.10 509.40 ± 36.22 567.40 ± 24.80 A 
Vitamin E (µg L-1) 3440.00 ± 50.00 7860.00 ± 2690.00
* 
7430.00 ± 870.00
* 
2106.17 ± 1261.98 E 
Notes: Means with asterisk are significantly different from the control at the 0.05 level. Means with different letters are significantly different between 
UPSN treatment groups at the 0.05 level. Data are reported as mean values ± standard deviation. NA: not-available. References: A) Afriyie-Gyawu et al. 
2005; B) Kohn and Clifford 2002; E) Seifi et al. 2009. 
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Table 9. Relative organ weights of SD rats receiving dietary UPSN at 0.25 and 2% for 13 weeks 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Group  Control UPSN 0.25% UPSN 2% 
Females  
   Brain 1.63 ± 0.11
 
1.60 ± 0.07
a
 1.66 ± 0.04*
b
 
Heart  0.82 ± 0.06 0.81 ± 0.06 0.81 ± 0.05 
L. kidney 0.80 ± 0.07
 
0.79 ± 0.08
 0.71 ± 0.04*
 
Liver  6.82 ± 0.40 6.92 ± 0.71 6.35 ± 0.27 
Lung  1.20 ± 0.10 1.17 ± 0.06 1.11 ± 0.07 
R. kidney 0.79 ± 0.06 0.77 ± 0.07 0.72 ± 0.05 
Spleen  0.52 ± 0.06 0.53 ± 0.06 0.51 ± 0.06 
Tibia 0.75 ± 0.13 0.70 ± 0.04 0.62 ± 0.07 
Uterus 0.63 ± 0.13 0.59 ± 0.12 0.55 ± 0.12 
Males  
   
Brain 1.65 ± 0.09 1.75 ± 0.15 1.69 ± 0.24 
Heart  1.36 ± 0.09
 
1.32 ± 0.10
a
 1.42 ± 0.11
b
 
L. kidney 1.31 ± 0.11 1.33 ± 0.12 1.32 ± 0.08 
Liver 12.34 ± 0.82
 
12.10 ± 0.89
 
11.35 ± 0.63* 
Lung  1.64 ± 0.21 1.65 ± 0.22 1.61 ± 0.14 
R. kidney 1.35 ± 0.14 1.39 ± 0.12 1.33 ± 0.09 
Spleen  0.77 ± 0.07   0.78 ± 0.08 0.79 ± 0.09 
Tibia 1.04 ± 0.04 1.06 ± 0.03 1.14 ± 0.10 
Notes: Means with asterisk are significantly different from the control at the 0.05 level. Means with 
different letters are significantly different between UPSN treatment groups at the 0.05 level. The 
relative organ weights (ROWs) were calculated by dividing the wet weight of each organ by the final 
body weight of the rat just before termination. ROWs have been multiplied by a factor of 102. Data are 
reported as mean values ± standard deviation.   
9
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The levels found in both UPSN and NS are below these PTDIs, hence negligible 
risk of dioxin/furan exposure is expected from these clays. The metal analysis for both 
clays also showed similarities. The amount of NS previously used in human trials was 
equal to 3 g/day/participant. In either clay, the concentrations of trace metals were below 
the TDIs or PTDIs that have been reported from different sources (Table 1). This is 
particularly important for future applications of UPSN in studies involving human 
subjects. The mineralogical analyses for UPSN and parent NS revealed similar 
structural, morphological and chemical characteristics, as expected. Similar pH values 
were obtained for both clays. Previous studies have found pH values ranging from 6.7 to 
9.6 (Marroquin-Cardona et al. 2009) and 7.1 to 9.6 (Kannewischer et al. 2006) for 
similar bentonite samples. Small differences were observed in moisture content, 
electrical conductivity, CEC, gypsum precipitation and the particle size distribution in 
dry and wet sates. Differences in moisture content may be related to batch to batch 
variations of the clay, while the greater electrical conductivity values obtained for NS 
are likely related to the presence of gypsum in this sample. The slightly higher CEC 
obtained for UPSN (89.2 cmol kg
-1
) could be related to the increased proportion of < 2 
µm particles in this clay, as revealed by the wet state fractionations. Common CEC 
values for smectites fall between 80-150 cmol kg
-1
 (Sparks 1995; Deer et al. 1978). 
Different authors have reported similar CEC ranges for other natural smectites 
(Kannewischer et al. 2006). High CEC values reflect the high capacity of the clays to 
potentially exchange/interact with diverse cationic components. These components have 
to be able to reach the interlayer galleries of the clays, implying that there are size, 
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charge and polarity restrictions. Regarding particle size in dry state, NS had a higher 
percentage of particles < 100 µm (20%) compared to UPSN (2%). UPSN had more 
particles in the size range of 100-45 µm (67%) and less particles with size < 45 µm 
(31%). This is attributed to the selection procedure used for UPSN. Importantly, in the 
wet state using water, UPSN had more ≤ 2 µm particles (75%) than in the dry state. This 
suggests that previous dry selection of particle size does not alter wet state particle size, 
which is the expected “active” state of these clays upon ingestion by animals and 
humans. Montmorillonite was the major mineral identified by XRD and FTIR in the clay 
fractions of both samples. Sand and silt fractions of both clays contained 
montmorillonite, quartz, feldspars and muscovite particles, as revealed by XRD and 
confirmed by SEM in UPSN. These findings were expected, since NS is the parent 
material from which UPSN has been selected. Although not considering safety, Dixon et 
al. (2008) proposed a criteria for selection of effective AF adsorbents based on several 
mineral characteristics, including Langmuir adsorption effectiveness of 0.30 (30 points), 
smectite predominance by XRD (30 points), CEC of 70 (5), pH ranging from 6.5-8.5 (5 
points), and FTIR evidence of structural Mg and Fe (10). According to this criterion, 
both UPSN and NS are very effective AF adsorbents. 
The pattern of AF sorption for both samples was the same, and the Qmax values at 
two pH levels were similar. Similar findings have been previously reported for other NS 
samples (Marroquin-Cardona et al. 2009; Phillips et al. 2009). The slight increase in 
Qmax observed for UPSN may be related to the higher amount of smectite particles in this 
sample, as revealed in the wet state fractionation analyses. 
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4.4.2 Animal study 
None of the differences observed for the growth parameters occurred in both 
sexes at both levels of UPSN. The statistical analysis of hematological and serum 
biochemistry parameters revealed some statistically significant differences in both sexes. 
Nevertheless, all of these differences fall between the ranges reported for control animals 
in different studies (Almodovar-Cuevas et al. 1985, Wolford et al. 1986). Na and Na/K 
ratio in males and females of UPSN groups were significantly greater than the control. 
According to the extractable bases determinations, these clays are able to leach some 
cations by means of exchange processes. Although the concentrations of NH4OAc used 
for the CEC and extractable bases determinations are higher than what can be expected 
in simulated physiological conditions, acetate and NH4OAc have been used as 
ingredients of Simulated Intestinal Fluid (Galia et al. 1998; Persson et al. 2009) for 
dissolution of pharmaceutical drugs.  The K levels in the males treated with UPSN were 
significantly lower than the controls, but no dose dependency was observed for this 
parameter. A possible explanation for the lower serum K levels in the males could be 
related to the cation exchange capacity of UPSN. It is possible that UPSN was able to 
exchange Na ions (in the clay) for K ions (from the diet). This phenomenon has been 
demonstrated with Na-cation-exchange resins that are orally administered to treat 
hyperkalemia (Elder 2005).  
Serum Ca levels were significantly greater in females treated with 0.25% UPSN 
and in males from both UPSN groups. Despite this, the Ca levels were within the normal 
range for < 6 month old rats and no evidence of dose dependency was found. In a similar 
102 
 
 
 
study using SD rats, Afriyie-Gywau et al. (2005) found a significant increase in serum 
Ca levels in females ingesting 0.5 and 2.0% of NS in the diet. Although not significant, 
the males of that study also showed increased levels of serum Ca. Using simulated 
gastric conditions for edible soils, Hodda et al. (2004) showed that bioavailability of Ca 
was correlated with amounts of Ca originally present in the soils. The potential 
supplementation of Ca by clays has also been suggested by Wiley and Katz (1998) and 
Wilson (2003). In our study, based on the XRD patterns, we suggest that calcite 
dissolution and exchangeable Ca from montmorillonite may act as potential sources of 
Ca supplementation.  
In the mineral and vitamin analysis, no significant differences were observed for 
Fe and vitamin A in the UPSN groups for either sex. However, significantly lower levels 
of serum Zn were detected in females and males from the 2% UPSN treatment group 
when compared to the control. Normal ranges of serum Zn for 3 month old rats are not 
reported in the literature, but the Zn levels in our study fell in the ranges previously 
reported for control SD rats that were 28 weeks old, according to Afriyie-Gyawu et al. 
(2005). Nonetheless, these findings are important since previous studies using a similar 
bentonite (hydrated sodium calcium aluminosilicate; HSCAS) reported potential 
interactions with Zn. Chung and Baker (1990) observed that chickens fed 1% HSCAS in 
the diet had significantly (p< 0.05) lower Zn levels measured in the tibia. Zn tibia 
concentration is a more reliable indicator of Zn levels in the body (Wedekind and Baker 
1990) since plasma Zn levels represent short-term changes in dietary zinc and can be 
influenced by factors independent of diet intake (Wallwork 1987). Based on results from 
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this study and Chung and Baker (1990), it can be suggested that Zn interactions may 
become important at higher inclusion levels of bentonites but not at lower levels. 
Regarding vitamin E, a significant increase in serum levels was noted for both doses of 
UPSN in both sexes. Afriyie-Gyawu et al. (2008b) observed a similar phenomenon in 
males during a human 3 month trial with NS clay. In our study, a treatment effect was 
clear and this could be related to a potential protective function the clay may exert on the 
vitamin. Specifically, it is possible that UPSN may prevent complete oxidation of the 
vitamin in the stomach, hence making it more bioavailable in the intestines. More work 
is warranted to determine the mechanism of this effect.  
In summary, UPSN showed similar AF sorption and mineral characteristics as 
parent NS; they are mainly composed of montmorillonite but also contained mica, 
feldspars and quartz minerals. We did not find evidence of overt toxicity due to the 
addition of UPSN at the levels used in the present study. Nevertheless, our findings with 
Na, Zn, K and vitamin E are important and further research on this clay is warranted. 
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V. TOXICOLOGICAL EVALUATION OF DIETARY SODIUM BENTONITE AS 
A POTENTIAL AFLATOXIN ENTEROSORBENT 
 
5.1 Introduction 
AFB1 is a potent hepatocarcinogen (Busby and Wogan 1984; Lopez et al. 2002) 
with genotoxic (Smela et al. 2001), immunotoxic (Hinton et al. 2003; Turner et al. 2003) 
and antinutritional (Pimpukdee et al. 2004) effects. AFB1 is a group 1 carcinogen (IARC 
2002) mainly produced by Aspergillus flavus and A. parasiticus fungi that commonly 
contaminate maize and peanuts (CAST 2003). The FDA (2011) has established action 
levels ranging from 20 µg kg
-1
 to 300 µg kg
-1
 for different feeds, according to their 
intended use for farm animals. The addition of bentonite in feeds (Harvey et al. 1991; 
Smith et al. 1994) is a feasible and promising method to reduce AFB1 exposure. 
Bentonites are montmorillonite-rich minerals that are commonly used as anti-caking 
agents or flow promoters, and are generally recognized as safe additives (GRAS) when 
used at levels not exceeding 2%. Montmorillonite is the most abundant mineral in 
bentonites and it has been reported as the active ingredient for AF binding. By adsorbing 
AFs from the diet, montmorillonite reduces toxin bioavailability to the blood and organs 
(Phillips 1999). Currently, a wide variety of purported AF binders are available in the 
marketplace, many of them having multi-mycotoxin binding claims. Of the clay-based-
additives, calcium bentonites have been extensively investigated in vitro and in vivo and 
have proven to effectively protect several species from the negative effects of AFB1 
(Smith et al. 1994; Phillips et al. 2006; Ledoux et al. 1999). On the other hand, sodium 
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bentonites have also been observed to prevent AF‟s effects on dairy cattle (Diaz et al. 
2004), but their potential interactions with other additives (Shryock et al. 1994), 
anticoccidials (Gray et al. 1998) and probable interactions with vitamin A (Briggs and 
Fox 1956; Laughland and Phillips 1956), as well as reports citing incomplete protection 
against AF effects (Abdel et al.1999; Voss et al. 1993), generates concern requiring 
more safety and efficacy studies on this material. 
Due to their natural origin, bentonites may contain undesirable contaminants like 
heavy metals, dioxins and furans. For these reasons, in vivo safety evaluation is essential 
before these materials are widely included in foods or feeds. Hence, our objectives were 
to elucidate the mineral characteristics of a sodium bentonite with potential AF sorption 
abilities and to determine its safety in a 13-week rodent model using Sprague Dawley 
rats.   
 
5.2 Materials and methods  
5.2.1 Sample information and chemicals 
Na-bentonite (Na-BENT) was obtained from AMCOL Specialty Minerals 
(Hoffman Estates, IL). For all experiments, ultrapure water (UP-H2O) was prepared by 
processing distilled water through a PURELAB Ultra (ELGA Woodridge, IL). AFB1 
from Aspergillus flavus was purchased from Sigma Aldrich (CAS 1162-65-8). All other 
reagents used in the sample preparation steps for the mineralogical analyses were 
analytical grade. 
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5.2.2 Dioxins and selected heavy metals 
Data for the 17 priority chlorinated dibenzo-p-dioxins/furans (CDDs/CDFs) in 
Na-BENT were performed by Analytical Perspectives (Wilmington, NC). Procedures 
followed the US Environmental Protection Agency (USEPA) method 8290 for sample 
preparation, clean-up and analysis with high resolution gas chromatography/high 
resolution mass spectrometry (HRGC/HRMS). Measurements of arsenic (As), cadmium 
(Cd), lead (Pb) and mercury (Hg) were also performed by the same laboratory. Samples 
were digested and prepared according to method SW846-3051 using a PerkinElmer 
Multiwave 3000 Anton Paar Microwave Reaction System. For mercury analyses, a 
PerkinElmer FIMS-100 CVAA analyzer was used following EPA method 7470A. Other 
metals were analyzed on a PerkinElmer ELAN 6100 ICP-MS using EPA method 6020.   
5.2.3 Mineralogical analyses 
Mineralogical analyses included an initial sample evaluation to determine 
moisture content and to assess the presence of carbonate minerals, sulfides, manganese 
oxides and evaporites. Other analyses included X-ray diffraction (XRD), Fourier 
transform infrared (FTIR) spectroscopy, scanning electron microscopy (SEM), 
transmission electron microscopy (TEM), cation exchange capacity (CEC), and 
extractable bases determinations in water and ammonium acetate (NH4OAs). Most 
mineralogical analyses were performed following standard procedures previously 
reported (Soukup et al. 2008) with minor modifications. The moisture content was 
determined by subtracting the oven dry weight (110 °C) from the air dry weight of 5 g of 
Na-BENT. The resulting value was expressed as % of moisture. Calcite (CaCO3) 
107 
 
 
 
presence was determined by using 1M hydrochloric acid (HCl). The presence of 
oxidizing/reducing components was evaluated by addition of hydrogen peroxide (H2O2 
30%). Presence of magnetic minerals was assessed by using a magnetic stir bar. 
Occurrence of evaporite minerals was qualitatively estimated by measurement of 
electrical conductivity (EC) and acetone precipitation. For EC measurement, 10 g of 
sample were weighed into 250 mL plastic bottles, the ratio of deionized water:solid used 
was 25:1. The sample was shaken for 30 min on a rotary shaker at room temperature and 
then centrifuged at 2000 rpm for 10 min. After centrifugation, the supernatant was used 
to measure the EC and pH sequentially. In order to evaluate the presence of gypsum, 2 
mL of the supernatant were collected in a glass tube followed by the addition of an equal 
volume of acetone.  
CEC and extractable bases determination in NH4OAc were done by the Soil 
Characterization Laboratory from the Soil and Crop Sciences Department at Texas 
A&M University, using a mechanically controlled variable rate leaching device as 
reported by Holmgren et al. (1977). Soluble bases using DI-water were determined by 
the Soil, Water and Forage Testing Laboratory at Texas A&M University, using a 
saturated paste extract method based on Rhoades and Clark (1978). An amount of 100 g 
of sample was used for this analysis. 
Prior to fractionation, removal of cementing and flocculating materials was done 
by treatment with pH 5 sodium acetate buffer at 90°C for 30 min, in duplicates. Organic 
matter (OM) was removed by using 30% H2O2. Na-BENT (same previously used for EC 
and pH measurements) was mixed with 50 mL of pH 10 sodium carbonate (Na2CO3) 
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dispersion solution, shaken and centrifuged at 2000 rpm for 10 min. The sand fraction 
was separated by passing the precipitated slurry through a 53 µm sieve. The silt fraction 
(2-53 μm) was separated from the clay fraction (<2 µm) by a centrifugation procedure 
based on Stokes‟ law. A pH 10 solution of Na2CO3 was used as dispersant. All 
supernatants (containing the clay fraction) were collected into beakers. Collected sand 
and silts were dried overnight at 105°C before weighing. The clay fraction was further 
flocculated with sodium chloride (NaCl) and then dialyzed until EC measurements were 
close to the water EC values (< 2 µS cm
-1
).  
XRD patterns were recorded in a Bruker D8 ADVANCE X-ray diffractometer.  
Sand and silt fractions were ground in a mortar and passed through a 140 mesh (105 µm) 
sieve and mounted as powder to collect the XRD patterns. Magnesium (Mg) and 
potassium (K) saturated clay were air dried on glass discs to obtain oriented films for 
XRD analysis. Mineral identification was determined using EVA (Bruker, Madison, WI) 
computer software. Infrared patterns were recorded in a Spectrum 100 FTIR 
(PerkinElmer, Inc.) using the diffuse reflectance infrared Fourier transform (DRIFT) 
method and the ATR method. For the DRIFT method, 0.005 g of sample was placed in a 
holder, using KBr as background material. For the ATR method, 1 mg of the clay 
fraction was mixed with 300 mg of KBr under a lamp to maintain dryness. Clay sample 
and KBr were mixed in a steel capsule for 30 seconds and then placed in a holder for 
reading.  
Silt samples were examined in a JEOL 6400 scanning electron microscope with 
energy dispersive X-ray (EDS) recording capability. For TEM analysis, a clay sample 
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was mounted on a holey carbon grid, and images were recorded in a JEOL 2010 
microscope with EDS capability.   
5.2.4 AFB1 sorption analyses 
Isotherms were performed based on methods reported by Grant and Phillips 
(1998) and previously described in detail by Marroquin-Cardona et al. (2009). Isotherms 
were conducted in triplicate at pH 2 and 6.5. Computer-generated equilibrium isotherms 
were extrapolated from additive data and fit to the Langmuir model (based on r
2
-values 
and randomness of the residuals). The parameters of Qmax (mol AFB1 kg
-1
 additive) and 
Kd were estimated to delineate the maximum sorption to the surface and the affinity of 
the sorption interaction. 
5.2.5 Rodent study experimental design  
Authorization for the study was obtained by Texas A& M University, according 
to the animal use protocol (AUP) 2008-39. Sprague Dawley®™ (SD) rats were obtained 
from Harlan (Houston, TX). Animal subjects in each group came from different litters to 
assure independence of samples. Four-week-old female (75-99 g) and male (100-124 g) 
rats were maintained with meal rodent feed 8604 Teklad Harlan (Madison, WI) and 
water ad libitum. After a brief acclimation period (5 days), the rats (1 rat per cage) were 
allocated to each particular group, including one control and two treatment groups. Each 
group consisted of 10 male and 10 female rats. The control group received basal rodent 
diet thorough the study while the treatment groups received formulations containing 
basal rodent diet with low (0.25%) and high (2%) concentrations of Na-BENT. Dietary 
clay concentrations were based on the minimum effective dose (0.25% w/w) of NovaSil 
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clay used in human studies for AF adsorption and the highest level allowed (2.0% w/w) 
by the FDA for use as a GRAS additive (Electronic Code of Federal Regulations 2010). 
Animals were housed in a climate controlled environment (temperature 22–25°C), 
artificially illuminated (12 hr dark/12 hr light) and free from chemical contamination. 
General appearance, behavior and signs of morbidity and mortality were inspected daily. 
Body weights were measured initially and every three days throughout the course of the 
study. Feed consumption was also recorded every three days. In total, body weight and 
feed consumption were recorded at 30 and 29 time points, respectively. Before 
termination, blood was drawn via cardiac puncture under isoflurane anesthesia. 
Following euthanasia, organs and tissues of interest were removed and evaluated for 
gross abnormalities. Wet weights of liver, kidneys, heart, lungs, brain, spleen, tibia, and 
uterus plus ovaries were recorded. The present study was simultaneously done with 
another trial investigating the safety of a refined Ca-bentonite (UPSN) (Marroquin-
Cardona et al. 2011). Both studies used the same control group as a reference.    
5.2.6 Hematological and serum biochemical analyses  
Hematology and serum biochemical parameters were analyzed by the Clinical 
Pathology Lab, Texas Veterinary Medical Diagnostics Lab (TVMDL) (College Station, 
TX). Hematological analysis of whole blood samples was conducted using an Abbott 
CELL-DYN 3700 Hematology Analyzer (Abbott Laboratories, Abbott Park, IL) and 
included hemoglobin (Hb) concentration, mean corpuscular hemoglobin (MCH), mean 
corpuscular hemoglobin concentration (MCHC), mean corpuscular volume (MCV), 
percent corpuscular volume (PCV), platelets, red blood cell (RBC) and white blood cell 
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(WBC) counts. Leukocyte differential analysis was performed manually by microscopic 
examination of blood smears and included neutrophils, lymphocytes, monocytes, and 
eosinophils. Serum biochemical parameters were assessed using an automated analyzer 
Modular P (Roche Diagnostics, Indianapolis, IN) and included albumin/globulin ratio 
(A/G), albumin (ALB), alkaline phosphatase (ALP), alanine aminotransferase (ALT), 
amylase (AMYL), aspartate aminotransferase (AST), blood urea nitrogen (BUN), 
calcium (Ca), cholesterol (CHOL), creatine kinase (CK), chloride (Cl), creatinine (CRT), 
gamma glutamyl-transferase (GGT), globulins (GLOB), glucose (GLUC), potassium 
(K), sodium (Na), Na/K ratio, phosphorous (P), total bilirubin (T-BIL) and total serum 
protein (TSP).  
Serum micronutrients iron (Fe) and zinc (Zn) were measured with a Hitachi 911 
(Roche Laboratories, Indianapolis, IN) and a Perkin Elmer Analyst 100 (PerkinElmer, 
Shelton, CT), respectively. Vitamin A and E were measured by HPLC according to 
previously reported methods by Weinman et al. (1999) and Rupérez et al. (2004).  
5.2.7 Statistical analysis 
First, to investigate the weight gained over time among the absolute control and 
the two doses of UPSN, a linear mixed model was constructed with the fixed effect 
treatment, sex, and treatment*sex interaction. Time was included as a continuous 
variable and tested for interactions with treatment and sex. Differences in final body 
weight (FBW) were investigated with a similar model that included the fixed effect 
treatment and the covariates initial body weight (IBW) and total feed consumption 
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(TFC) as explanatory variables. Backward selection was done by removing one term at a 
time, starting with non-significant interactions (p > 0.05). 
A second analysis was performed to investigate differences in biochemical 
parameters, relative organ weights and selected vitamins and minerals among the 
absolute control and the two doses of UPSN for males and females separately. A linear 
or a generalized linear mixed model was constructed with the fixed effect treatment as 
the only independent variable. The MIXED and GLIMMIX procedures were used for all 
statistical analyses using SAS 9.2 with Enterprise Guide 4.1. In all these analyses, the 
effect of subject (i.e. rat) was considered as random, since all animals came from 
different litters (non relatives in each group). All post-test comparisons were adjusted by 
the method of Tukey-Kramer. Finally, monocyte counts and T-BIL were analyzed with 
non-parametric tests using SPSS 14.0. Data for T-BIL were classified in categories 
before analysis. Kruskal-Wallis test followed by Mann-Whitney test for multiple 
comparisons were used to detect individual differences between groups.  
 
5.3 Results  
Dioxins/furans detected in Na-BENT were tetrachlorodibenzo-p-dioxin, 
hexachlorodibenzo-p-dioxin, heptachlorodibenzo-p-dioxin, tetrachlorodibenzo-p-furan, 
and pentachlorodibenzo-p-furan. The average calculated dioxin/furan toxic equivalents 
(TEQs) for Na-BENT were 0.0811 pg g
-1
. The heavy metal levels found in Na-BENT 
were 0.01 mg g
-1
 for As, 0.003 mg g
-1
 for Cd, <0.00003 mg g
-1
 for Hg, and 0.03 mg g
-1
 
for Pb. Using the tolerable daily intake (TDI) levels reported by the JECFA (2000; 2007; 
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WHO 1989), the TDIs calculated for a 70 kg BW person, are 0.14 mg for As, 0.07 mg 
for Cd, 0.01 mg for Hg, and 0.21 mg for Pb.  
5.3.1 Mineralogical analyses 
Little reaction following HCl application suggested that calcite and other 
carbonate minerals were not present in significant amounts in Na-BENT (Table 10). 
Similarly, little or no reaction following H2O2 treatment suggested that Na-BENT does 
not contain significant amounts of oxidizing/reducing components (e.g. manganese 
oxides) or organic matter. The pH of the sample was 8.3 and it is in the ranges reported 
for clay samples containing smectites (Marroquin-Cardona et al. 2009; Kannewischer et 
al. 2006). The EC values observed suggested that gypsum was present in this sample. 
This finding was confirmed by XRD powder mounts, in which a gypsum peak (7.6 Å) 
was evident (Figure 27). As a moderate soluble sulfate mineral, gypsum is able to 
increase EC readings when dissolved. The percentages calculated for each fraction 
showed that this sample is mainly composed of clay particles (90%). CEC values were 
calculated to be 90.5 cmol kg
-1
. The major minerals identified in Na-BENT powder 
mount XRD were montmorillonite (12.5 Å), gypsum (7.6 Å) and quartz (3.3 Å) (Figure 
27). 
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Table 10. Mineral characteristics of Na-BENT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parameter Na-BENT 
Moisture % 6.4 
pH  8.3 
EC (µS cm
-1
) 751.0 
HCl reaction Little 
H2O2 reaction Little 
Magnetic minerals ND 
Free iron oxides (%) 0.8 
Sand (>53µm) (%)  3.0 
Silt (2-53µm) (%)  7.0 
Clay (<2µm) (%)  90.0 
Mica (%) 2.1 
CEC (cmol kg
-1
) 90.5 
Extractable cations (cmol kg
-1
)  
Ca  32.5 
K 1.4 
Mg 19.9 
Na 58.8 
Soluble cations DI-water (mEq L
-1
)*  
Ca 2.7 
K 0.5 
Mg 1.6 
Na 31.9 
Notes: *Soluble bases were measured in DI-water vacuum extracts from a 
paste according to Rhoades and Clark, 1978; ND: non-detected. 
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Figure 27. Powder mount XRD pattern of Na-bentonite. Minerals identified included montmorillonite (12.5, 4.48, 1.49 Å), 
gypsum (7.62 and 4.28 Å) quartz (3.34 Å), calcite (3.03 Å), orthoclase feldspars (3.75 Å) and andesine (4.04, 3.22 and 3.18 
Å).  
1
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Peaks for quartz and mica (10.0 Å) as well as peaks of feldspars from the 
plagioclase group (andesite) and   the orthoclase group (sanidine and albite) were 
observed in the sand and silt fractions. Montmorillonite presence was confirmed after 
XRD analysis of the clay fraction exchanged with Mg
 
and K. After treatment with Mg 
and glycerol, the d-space of the most intense montmorillonite peak increased from ~12 
to ~18 Å. Samples exchanged with K and air dried showed a peak of ~12 Å, which is in 
the range expected for montmorillonites (10-14 Å). After heating the samples exchanged 
with K at 330°C and 550°C, the ~12 Å peak changed to ~10 Å respectively. A quartz 
peak was observed in the clay fraction saturated with Mg
 
(air dried), glycerol and K 
saturated, which suggests silica could be present. Opal was verified in the KBr pattern 
where a 622 cm
-1
 band was observed. The characteristic bands of montmorillonite were 
observed in the DRIFT (3636 cm
-1
) and ATR (3632 cm
-1
) patterns, confirming XRD 
findings. SEM findings for Na-BENT revealed a variety of particle shapes and 
compositions. Important findings included a small particle compatible with monazite 
which contained phosphorous (P) and some lanthanides and actinides like cerium (Ce), 
neodymium (Nd), samarium (Sm) and protactinium (Pa) (Figure 28A), and  a particle 
composed of calcium phosphate compatible with hydroxyapatite (Ca5(PO4)3(OH) 
(Figure 28B). The main phenomenon observed in the TEM images was the folding 
tendency of the montmorillonite particles as illustrated in Figure 28C. The particles are 
shown as thin films of considerable length (3-5 µm). Moiré patterns were also observed 
in some particles (Figure 28D). 
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Figure 28. SEM and TEM images of Na-bentonite. A) SEM image of monazite 
particle in Na-BENT sample. B) Hydoxyapatite particle in Na-BENT. C) Moiré 
patterns observed in platelets of Na-BENT. D) Smectite particle depicting sheets 
and rolls morphology with an approximate length of 1 µm, according to the scale 
bar. This morphology is commonly observed for effective aflatoxin adsorbents, 
according to Mulder et al. (2008). 
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5.3.2 AFB1 sorption analyses 
 The parameters of Qmax and Kd calculated for Na-BENT demonstrated the 
effectiveness of the clay in vitro. Na-BENT depicted a favorable AF sorption pattern 
characterized as L shape, at both pH levels (Figure 29). Specifically, an L2 shape was 
documented for Na-BENT at pH 6.5 with a calculated Qmax value of 0.34 mol AFB1 kg
-1
. 
A slightly higher Qmax of 0.39 mol AFB1 kg
-1 
was calculated at pH 2.0, for which an L1 
pattern was observed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29. AFB1 adsorption isotherms onto Na-BENT at pH 6.5 and 2. At both pH levels, 
Na-BENT depicted an L-shape pattern characteristic of planar arrangement of molecules 
adsorbed on the surface. The bend on the pattern indicates that the sorbent is reaching 
saturation as the concentration of the solute is increased (pH 6.5). The Qmax values 
calculated were similar at both pH levels, with 0.33 and 0.39 mol AFB1 kg
-1
 at pH 6.5 and 
2, respectively. 
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5.3.3 Rodent study outcomes  
No apparent toxicity effects due to consumption of bentonite at either dose were 
noticed throughout the study. All rats, with the exception of two males, remained healthy 
and active without noticeable changes in behavior. Two males of the 0.25% Na-BENT 
group had black discharge from one eye and they were treated with topic antibiotic 
ointment. The discharge disappeared within 4 days.  
Males gained more weight than the females (p ≤ 0.0001), as expected. The 
interaction between treatment * gender was not significant (p = 0.6780). Weight gain 
across time was different in at least one of the treatment groups (p ≤ 0.0001). Rats in the 
control group gained more weight than rats in the 2% group by time 5 (p = 0.0019) and 
consecutively up to time 30 (p ≤ 0.0001). Similarly, animals in the control group gained 
more weight than 0.25% by time 20 (p = 0.0131) and consecutively at time 30 (p = 
0.0002). Significant differences were observed between the control and the treatment 
groups for some of the growth parameters in the females (Table 11). TFC and IBW were 
not significant factors for explaining the differences in FBW of the females. Similarly, in 
males, IBW was not a significant factor for explaining the differences in FBW. 
However, in males there was a linear relationship between TFC (p = 0.0278 for TFC * 
treatment interaction) and FBW in both, the 0.25% and 2% Na-BENT groups, meaning 
that TFC influenced FBW. 
120 
 
 
 
Table 11. Growth parameters of SD rats receiving dietary Na-BENT at 0.25 and 2% for 13 weeks 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Group  Control Na-BENT 0.25% Na-BENT 2% 
Females  
FBW (g) 243.85 ± 13.49 231.03 ± 7.46* 226.60 ± 15.63* 
FCE (g) 13.24 ± 2.74 14.72 ± 1.74 15.82 ± 1.69 
IBW (g) 99.52 ± 4.75 95.30 ± 3.14 86.33 ± 4.62* 
TBWG (g) 144.33 ± 10.12 135.73 ± 7.35 140.27 ± 13.70 
TFC (g) 1899.17 ± 341.57 1995.90 ± 231.58 2205.14 ± 169.50 
Males  
FBW (g) 406.45 ± 19.99 397.39 ± 24.44 392.73 ± 19.19 
FCE (g) 7.42 ± 0.70 7.78 ± 0.53 7.68 ± 0.45 
IBW (g) 120.87 ± 3.65 121.83 ± 6.40
a
 115.66 ± 4.96*
b
 
TBWG (g) 285.58 ± 20.18 275.56 ± 21.93 277.07± 21.89 
TFC (g) 2110.08 ± 104.45 2135.83 ± 101.44 2120.53 ± 66.08 
Notes: Means with asterisk are significantly different from the control at the 0.05 level. Means with 
different letters are significantly different between Na-BENT groups at the 0.05 level. Data are reported as 
mean values ± standard deviation. FBW: Final body weight; FCE: Feed conversion efficiency; IBW; Initial 
body weight; TBWG: Total body weight gain; TFC: Total feed consumption 
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5.3.4 Hematological and serum biochemistry analyses  
Some differences between the control and at least one of the Na-BENT treatment 
groups were observed for the hematological and vitamin and metal serum parameters 
(Table 12). Most relevant findings included the increased vitamin E levels observed in 
both females and males of Na-BENT groups. Another important finding in the females 
was the reduction and increment of the RBC counts and MCV values respectively, in the 
Na-BENT groups. In the males of Na-BENT groups, the most important finding besides 
vitamin E, was the reduction in serum levels of Zn. Males of Na-BENT groups had 
significantly lower Zn levels than the controls, yet the levels were within normal ranges 
previously reported for control 28 weeks old SD rats, according to Afriyie-Gyawu et al. 
(2005). Normal ranges of serum Zn for 3 month old rats are not available in the 
literature. Concerning serum vitamin levels, the males on 2% Na-BENT had 
significantly lower vitamin A levels than the control group.  
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Table 12. Hematological parameters and serum Fe, Zn, Vitamins A and E of SD rats receiving dietary Na-BENT 
 
 
 Control Na-BENT 0.25% Na-BENT 2% Normal values Reference 
Females      
Hb (g dL
-1
) 14.19 ± 0.33 13.90 ± 0.72 13.68 ± 0.31* 14.30 ± 0.83 F 
MCH (pg) 18.44 ± 1.70 18.66 ± 1.98 19.62 ± 3.10 19.8 ± 0.94 F 
MCHC (g dL
-1
) 34.43 ± 0.72 34.20 ± 0.71 33.95 ± 0.79  34.40 ± 0.50  D 
MCV (fl) 55.85 ± 1.76 57.96 ± 1.00* 57.77 ± 1.20* 57.90 ± 2.10 D 
PCV (%) 41.24 ± 1.53 40.65 ± 1.99 40.32 ± 1.03 38.10 ± 2.43 F 
Platelets (x10
3
) µL
-1
 468.20 ± 77.83 483.00 ± 138.59 484.66 ± 280.62 471.68 ± 38.77 B 
RBCs (x10
6
) µL
-1
 7.39 ± 0.29 7.02 ± 0.36* 6.98 ± 0.21* 7.02 ± 0.40 D 
WBC µL
-1
 3944.00 ± 962.96 5029.00 ± 1314.55
a
 12595.00 ± 4759.51* 7840.00 ± 2950.00 C 
Fe (µg dL
-1
) 254.67 ± 38.20 247.73 ± 52.63 233.02 ± 40.54 220 ± 130 C 
Zn (µg mL
-1
) 1.24 ± 0.18   1.16 ± 0.11 1.14 ± 0.14 1.05 ± 0.09 A 
Vitamin A (µg L
-1
) 267.31 ± 27.78 270.12 ± 17.75 250.16 ± 31.42 254.10 ± 6.00 A 
Vitamin E (µg L
-1
) 3560.00 ± 40.00 8030.00 ± 1220* 9180.00 ± 1210* NA  
Males 
Hb (g dL
-1
) 14.51 ± 0.46 14.98 ± 0.56
a
 14.22 ± 0.35
b
 14.70 ± 1.22 F 
MCH (pg) 18.78 ± 0.45 18.76 ± 0.27 18.75 ± 0.59 19.00 ±1.09 F 
MCHC (g dL
-1
) 33.77 ± 0.71 34.05 ± 0.53 33.58 ± 0.37 34.10 ± 0.40 D 
MCV (fl) 55.78 ± 2.25 55.07 ± 1.06 55.84 ± 1.40 59.50 ± 2.00 D 
PCV (%) 43.10 ± 1.73 44.00 ± 1.94 42.34 ± 0.80 39.90 ± 3.49 F 
Platelets (x10
3
) µL
-1
 418.60 ± 133.39 543.10 ± 145.15 668.10 ± 122.03* 471.68 ± 38.77  B 
RBCs (x10
6
) µL
-1
  7.73 ± 0.32 7.99 ± 0.31
a
 7.58 ± 0.19
b
 7.82 ± 0.83 F 
WBC µL
-1
 7238.00 ± 2462.55 8235.00 ± 1509.11
 
10850.00 ± 2912.90* 7840.00 ± 2950.00 C 
Fe (µg dL
-1
) 115.89 ± 10.92 109.96 ± 16.69 124.32 ± 23.81 152 ± 70 C 
Zn (µg mL
-1
)   1.50 ± 0.09   1.33 ± 0.09*     1.23 ± 0.08*      1.29 ± 0.04 A 
Vitamin A (µg L
-1
) 530.80 ± 39.44 519.74 ± 77.78 441.55 ± 67.45* 567.40 ± 24.80 A 
Vitamin E (µg L
-1
) 3440.00 ± 50.00 7210.00 ± 870* 8570.00 ± 1300* 2106.17 ± 1261.98 E 
Notes: Means with asterisk are significantly different from the control at the 0.05 level. Means with different letters are significantly different between Na-
BENT groups at the 0.05 level. Data are reported as mean values ± standard deviation. Hb: hemoglobin; MCH: mean cell hemoglobin; MCHC: mean 
corpuscular hemoglobin concentration; MCV: mean corpuscular volume; PCV: packed cell volume; RBC: red blood cell; WBC: white blood cell. 
References: A) Afriyie-Gyawu et al. 2005; B) Almodovar et al. 1985; C) Kohn and Clifford 2002; D) Lillie et al. 1996; E) Seifi et al. 2009; F) Woldford et 
al. 1986.  
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Table 13. Serum biochemical parameters of SD rats receiving dietary Na-BENT at 0.25 and 2% for 13 weeks 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Treatment 
Parameter Control Na-BENT 0.25% Na-BENT 2% Normal values Reference 
Females 
A/G Ratio   2.41 ± 0.11 2.22 ± 0.18* 2.38 ± 0.15 2.13 ± 0.18 D 
ALB (g dL
-1
) 3.74 ± 0.15 3.74 ± 0.18 3.84 ± 0.13 3.41 ± 0.23 A 
ALP (U L
-1
) 58.40 ± 14.23 57.70 ± 19.13 71.10 ± 19.67 117 ± 41.7 B 
ALT (U L
-1
) 54.70 ± 9.47 56.78 ± 9.52 50.10 ± 6.95 44.00 ± 23.9 C 
AMYL (U L
-1
) 1258.40 ± 112.41 1247.30 ± 155.68 1531.10 ± 447.64 1703 ± 164.32 D 
AST (U L
-1
) 138.20 ± 42.38 155.77 ± 52.67 92.80 ± 16.98* 93.00 ± 30.3 C 
BUN (mg dL
-1
) 18.44 ± 1.70 18.66 ± 1.98 19.62 ± 3.10 21.00 ± 3.90 C 
Ca (mg dL
-1
) 9.34 ± 0.32 9.62 ± 0.24
a
 10.02 ± 0.41*
b
 10.36 ± 0.32 A 
CHOL (mg dL
-1
) 86.73 ± 9.33 85.01 ± 11.97 85.53 ± 4.59 89.00 ± 23.00  C 
CK (U L
-1
) 815.11 ± 360.20 1124.11 ± 802.88
a
 363.80 ± 116.44*
b
 210.00 ± 109 A 
Cl (mEq L
-1
) 94.50 ± 19.54 101.50 ± 1.43 101.20 ± 1.13 104.00 ± 2.40 B 
CRT (mg dL
-1
) 0.29 ± 0.03 0.33 ± 0.03 0.31 ±0.02 0.55 ± 0.10 A 
GGT (U L
-1
)  <3.0 <3.0 <3.0 <3.0 D 
GLOB (g dL
-1
)   1.55 ± 0.08 1.69 ± 0.16 1.62 ± 0.11 1.91 ± 0.09 D 
GLUC (mg dL
-1
) 180.10 ± 15.62 181.70 ± 23.35 186.50 ± 29.45 199.80 ± 21.60 A 
K (mEq L
-1
) 5.71 ± 1.33 4.91 ± 0.34† 4.57 ± 0.53† 4.76 ± 0.44 A 
Na (mEq L
-1
) 129.80 ± 25.68 140.60 ± 0.97† 140.40 ± 1.35† 142.00 ± 2.00 A 
Na/K Ratio 23.04 ± 2.99 28.77 ± 1.92* 31.08 ± 3.42* ~29 A 
P (mg dL
-1
) 5.56 ± 0.87 5.51 ± 0.40 5.29 ± 0.45 5.80 ± 1.10 B 
T-BIL (mg dL
-1
) 0.09 ± 0.05 0.14 ± 0.02 0.10 ± 0.04 0.30 ± 0.24 C 
TP (g dL
-1
) 5.29 ± 0.21 5.43 ± 0.28 5.46 ± 0.20 6.17 ± 0.33 A 
Notes: Means with asterisk are significantly different from the control at the 0.05 level. † These parameters resulted significantly different from the control when 
an outlier was removed. Means with different letters are significantly different between Na-BENT groups at the 0.05 level. Data are reported as mean values ± 
standard deviation. ALB: albumin; ALP: alkaline phosphatase; ALT: alanine aminotransferase; AMYL: amylase; AST: aspartate aminotransferase; BUN: blood 
urea nitrogen; CHOL: cholesterol; CK: creatine kinase; CTR: creatinine; GGT: gamma-glutamyl transferase; GLOB: globulin; GLUC: glucose; T-BIL: total 
bilirubin; TP: total protein. References: A) Afriyie-Gyawu et al. 2005; B) Kohn and Clifford 2002; C) Lillie et al. 1996; D) Woldford et al. 1986.  
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Table 13. continued 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Group  
Parameter Control Na-BENT 0.25  % Na-BENT  2.0 % Normal values Reference 
Males 
A/G Ratio 1.93 ± 0.15 1.80 ± 0.14 1.79 ± 0.13 1.37 ± 0.18 D 
ALB (g dL
-1
) 3.42 ± 0.15 3.68 ± 0.15* 3.64 ± 0.11* 3.40 ± 0.20 B 
ALP (U L
-1
) 79.20 ± 9.47 69.20 ± 15.87
a
 91.10 ± 19.15
b
 130 ± 43.7 B 
ALT (U L
-1
) 61.30 ± 19.38 56.40 ± 14.45 51.70 ± 9.93 49.00 ± 24.1 B 
AMYL (U L
-1
) 2316.00 ± 211.13 2386.40 ± 211.69 2461.68 ± 214.64 2671.00 ± 89.00 D 
AST (U L
-1
) 116.80 ± 49.97 105.40 ± 26.47 89.40 ± 23.17 97.00 ± 28.40 C 
BUN (mg dL
-1
) 19.41 ± 2.63 22.03 ± 2.46 22.05 ± 1.92 20.00 ± 3.20 C 
Ca (mg dL
-1
) 9.12 ±  0.39 9.67 ± 0.19* 9.91 ± 0.30* 10.48 ± 0.28 A 
CHOL (mg dL
-1
) 85.37 ± 10.16 92.38 ± 13.49 89.22 ± 9.12 75.00 ± 19.80 C 
CK (U L
-1
) 432.22 ± 227.32 368.30 ± 86.66 399.36 ± 248.12 222.00 ± 109.00 A 
Cl (mEq L
-1
) 98.30 ± 2.26 100.60 ± 0.97 100.20 ± 1.35 103.00 ± 1.90 B 
CRT (mg dL
-1
) 0.26 ± 0.03 0.29 ± 0.02 0.28 ± 0.01 0.54 ± 0.08 A 
GGT (U L
-1
) <3.0 <3.0 <3.0 <3.0 D 
GLOB (g dL
-1
) 1.78 ± 0.15 2.05 ± 0.18* 2.04 ± 0.12* 2.51 ± 0.25 D 
GLUC (mg dL
-1
) 192.70 ± 37.05 186.60 ± 23.14 204.20 ± 16.90 212.40 ± 28.8 A 
K (mEq L
-1
) 7.23 ± 0.66 5.30 ± 0.30* 5.16 ± 0.13* 5.30 ± 0.39 A 
Na (mEq L
-1
) 135.20 ± 2.74 140.60 ± 0.97* 140.50 ± 2.01* 142.00 ± 2.00 A 
Na/K Ratio 18.86 ± 1.74 26.62 ± 1.51* 27.23 ± 0.81* ~26 A 
P (mg dL
-1
) 5.92 ± 0.39 6.18 ± 0.24 6.24 ± 0.47 7.30 ± 1.50 B 
T-BIL (mg dL
-1
) 0.01 ± 0.03 0.11 ± 0.02* 0.02 ± 0.04 0.30 ± 0.16 C 
TP (g dL
-1
) 5.20 ± 0.25 5.73 ± 0.27* 5.68 ± 0.13* 5.85 ± 0.23 A 
Notes: Means with asterisk are significantly different from the control at the 0.05 level. † These parameters resulted significantly different from the control when 
an outlier was removed. Means with different letters are significantly different at the 0.05 level. Data are reported as mean values ± standard deviation. ALB: 
albumin; ALP: alkaline phosphatase; ALT: alanine aminotransferase; AMYL: amylase; AST: aspartate aminotransferase; BUN: blood urea nitrogen; CHOL: 
cholesterol; CK: creatine kinase; CTR: creatinine; GGT: gamma-glutamyl transferase; GLOB: globulin; GLUC: glucose; T-BIL: total bilirubin; TP: total protein. 
References: A) Afriyie-Gyawu et al. 2005; B) Kohn and Clifford 2002; C) Lillie et al. 1996; D) Woldford et al. 1986.  
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Other important outcomes in the females of both Na-BENT groups included 
increased Na/K ratio, and potentially increased and decreased serum Na and K, 
respectively (Table 13). Both of these parameters were significantly different only when 
their respective values in an outlier (rat 3) from the control group were removed. No 
specific reason other than better explanation of the data justified the removal of the 
outlier.  Similar results for these parameters were observed for the males of Na-BENT 
group, for which serum Na and Na/K ratio were increased and serum K was decreased, 
when compared to the control (Table 13).  
Calcium was also significantly increased in the males of Na-BENT groups. In the 
present study, the females of 2% Na-BENT had significantly increased levels of Ca but 
not the ones from the 0.25% group.  
The rest of the parameters measured in blood and serum were either not 
significantly different from the control group or if different from the control, they fell in 
the ranges of normally expected values. Similarly, even when several parameters were 
significantly different from the control, the majority was found in the normal ranges 
reported for control animals in several studies (Tables 12 and 13) and no evidence of 
dose dependency was evident.  
5.3.5 Relative organ weights  
Isolated differences were observed for some of the relative organ weights for 
males (Table 14). Specifically, liver and brain weights of males of both Na-BENT 
groups were different when compared to the control. However, this was not observed in 
the females and there was not a dose dependency trend. 
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Table 14. Relative organ weights of SD rats receiving dietary Na-BENT at 0.25 and 
2.0% for 13 weeks 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Group  Control 
Na-BENT 0.25 
% 
Na-BENT 2 % 
Females  
   Brain 1.63 ± 0.11 1.58 ± 0.07 1.59 ± 0.08 
Heart  0.82 ± 0.06 0.80 ± 0.05 0.82 ± 0.07 
L.kidney 0.80 ± 0.07 0.75 ± 0.04 0.73 ± 0.05 
Liver 6.82 ± 0.40 6.30 ± 0.74 6.51 ± 0.88 
Lung  1.20 ± 0.10 1.17 ± 0.08 1.15 ± 0.13 
R. kidney 0.79 ± 0.06 0.74 ± 0.03 0.74 ± 0.03 
Spleen 0.52 ± 0.06 0.54 ± 0.05 0.51 ± 0.06 
Tibia 0.75 ± 0.13 0.75 ± 0.08 0.69 ± 0.03 
Uterus 0.63 ± 0.13 0.59 ± 0.10 0.75 ± 0.31 
Males  
   
Brain 1.65 ± 0.09 1.76 ± 0.13* 1.76 ± 0.09* 
Heart 1.36 ± 0.09 1.35 ± 0.10 1.31 ± 0.19 
L.kidney 1.31 ± 0.11 1.24 ±0.10 1.17 ± 0.10 
Liver  12.34 ± 0.82 11.16 ± 0.88* 10.84 ± 1.00* 
Lung 1.64 ± 0.21 1.53 ± 0.11 1.61 ± 0.14 
R.kidney 1.35 ± 0.14 1.27 ± 0.11 1.21 ± 0.11 
Spleen 0.77 ± 0.07   0.77 ± 0.05 0.79 ± 0.17 
Tibia 1.04 ± 0.04 0.95 ± 0.08 1.03 ± 0.05 
Notes: Means with asterisk are significantly different from the control at the 0.05 level. Means 
with different letters are significantly different at the 0.05 level. The relative organ weights 
(ROWs) were calculated by dividing the wet weight of each organ by the final body weight of the 
rat just before termination. ROWs have been multiplied by a factor of 102. Data are reported as 
mean values ± standard deviation 
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5.4 Discussion  
The dioxins/furans and heavy metal levels found in Na-BENT were low. The 
Joint FAO/WHO Expert Committee on Food Additives (JECFA) has placed a 
provisional tolerable daily intake (PTDI) values for dioxins of ~2.3 pg kg-bw
-1
 day
-1
 
(FAO/WHO 2001) for humans. To reach the PTDI levels, and assuming bioavailability 
of the dioxins in the gastrointestinal tract, an average 70 kg person will have to consume 
about 2 kg of Na-BENT per day. Under realistic conditions, consumption of Na-BENT 
will be at lower levels that confer negligible risk of dioxin exposure. Similarly, 
according to the TDIs calculated for heavy metals such as As, Cd, Hg and Pb for a 70 kg 
person, the ingestion of 3 g of Na-BENT, which is maximum level of clay used in other 
studies to reduce AF bioavailability, does not seem to be a risk of exposure to these 
metals.  
The mineral analyses for Na-BENT revealed similar characteristics expected for 
bentonites. The sample was mainly composed of montmorillonite but also contained 
mica, gypsum, feldspars and quartz minerals. Montmorillonite was the major mineral 
identified by XRD, FTIR and TEM of the clay fraction. Sand and silt fractions contained 
quartz, feldspars and mica particles as revealed by XRD and confirmed by SEM. The 
CEC obtained for Na-BENT was in the ranges reported for other natural smectites 
(Kannewischer et al. 2006; Marroquin-Cardona et al. 2011). Common CEC values for 
smectites fall between 80-150 cmol kg
-1
 (Sparks 1995; Deer et al. 1978). The particle 
morphology of sheets and rolls observed in TEM is a common feature observed for 
effective AF adsorbents, according to Mulder et al. (2008). The presence of Moiré 
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patterns in smectites, as in the present study, can be indicative of coarse particles 
composed of differently oriented plates (Singer et al. 1972). 
Regarding the adsorption isotherms for AF Na-BENT depicted L-shape pattern at 
both pH levels. Specifically, L1 pattern was observed at pH 2 and L2 pattern at pH 6.5. 
L1 shape patterns are indicative of sorption processes in approximation of a plateau, 
while L2 pattern generally suggests that the plateau has been reached (Giles et al. 1960; 
Grant and Phillips et al. 1998). The differences in patterns may have accounted for the 
different Qmax values calculated at both pH levels. Ongoing experiments are focused on 
elucidating the specific effects of the pH on the behavior of montmorillonite and its 
sorption of AF. 
The main purpose of the mineral characterization was to investigate its potential 
correlation with the safety/toxicity of this clay in vivo. In general, no dose-dependent 
effects resulted from the ingestion of Na-BENT for up to 3 months in rats. Nonetheless, 
it was apparent that the bentonite was able to increase Ca, Na, vitamin E, and to decrease 
K, in serum of males and females at both inclusion levels (0.25% and 2.0%). In the 
specific case of vitamin E, the effect of Na-BENT is not clear, but a possible protective 
effect of the clay on this vitamin has been suggested (Marroquin-Cardona et al. 2011).  
Calcium was another parameter that was also significantly increased in the males 
of Na-BENT groups. Similar studies using SD rats have found significant increases in 
serum Ca levels in females ingesting 0.5 and 2.0% of NovaSil clay  (Afriyie-Gywau et 
al. 2005) and in females and males ingesting 0.25 and 2% refined NovaSil clay in the 
diet (Marroquin-Cardona et al. 2011). In the present study, the females of 2% Na-BENT 
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had significantly increased levels of Ca but not the ones from the 0.25% group. The 
potential supplementation of Ca by clays has been previously suggested (Wiley and Katz 
1998; Wilson 2003) and in the present study, based on the XRD patterns; the Ca sources 
in Na-BENT may include calcite, gypsum and montmorillonite. 
On the contrary, concerning serum vitamin A levels, the males on 2% Na-BENT 
had significantly lower levels than the control group. Interactions of vitamin A and 
bentonites have been previously reported in studies using chickens and rats (Brigs and 
Fox 1956; Laughland and Phillips 1954), were these interactions occurred at high 
inclusion rates (≥ 3%) of Na-bentonites. Nonetheless, other studies in SD rats using 2% 
inclusion of similar clays (Ca-montmorillonite) have shown no significant changes in 
serum vitamin A levels, when compared to the control (Afriyie-Gyawu et al. 2005; 
Marroquin-Cardona et al. 2011).  
Serum Zn was reduced in the males at both inclusion levels of bentonite, a trend 
previously observed for other bentonites (Marroquin-Cardona et al. 2011). Interactions 
of similar clays (e.g. hydrated sodium calcium aluminosilicates; HSCAS) with Zn have 
been reported by Chung and Baker (1990). In that study, the authors observed 
significantly (p < 0.05) lower Zn levels in the tibia of chickens fed 1% HSCAS in the 
diet. Zn tibia concentration is a more reliable indicator than serum Zn concentration of 
Zn levels in the body (Wedekind and Baker 1990). Nevertheless, serum and plasma Zn 
are useful to evaluate short-term changes in dietary zinc as it has been shown in studies 
feeding Zn deficient diets to SD rats (Baltaci et al. 2005; Sunnar et al. 2009). The results 
of the present study are similar to what we observed in a paired study using a refined 
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NovaSil clay (uniform particle size NovaSil; UPSN) (Marroquin-Cardona et al. 2011). In 
that study, a significant reduction of Zn (P < 0.05) was documented just in the males 
receiving the high dose of UPSN (2%). The difference between both studies is the type 
of bentonite used. For instance, UPSN is a montmorillonite rich Ca-bentonite with 
limited expansive behavior, while the bentonite in the present study is known to contain 
high amounts of Na and to display a high expansive behavior. Both bentonites are 
reported to have high CEC values and it has been previously proposed that these types of 
clays may retain cation exchange abilities in the gastrointestinal tract (Marroquin-
Cardona et al. 2011). Together, these characteristics may potentially explain the 
reduction and increase of serum Zn and Na in males of Na-BENT groups, respectively. 
Nevertheless, the bentonite effects on Zn were not observed in the females and we do 
not have a clear explanation available.  
Some differences from the control were observed, but no evidence of dose 
dependency was found and most parameters fell within ranges reported as normal 
physiological levels. Nonetheless, due to inherent cation exchange capacity of these 
types of clays, our findings with Ca, Na, K and Zn require further research.  
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VI. SUMMARY 
 
Among the several natural toxic agents found in the food supply, mycotoxins are 
the most prevalent. Particularly, AFs are carcinogens with strong hepatotoxic, 
immunosuppressive and antinutritional effects that are commonly found in staple foods 
worldwide. Specifically, AFB1 is the most toxic of four naturally occurring AFs (i.e., B1, 
B2, G1 and G2) and is considered a Group 1 carcinogen by the International Agency for 
Research on Cancer (IARC 2002). The exposure to AFs is unavoidable and strategies to 
ameliorate their toxicity in animals and humans are needed. Extensive research based on 
clay therapy has been developed to protect animals against this toxin (Phillips et al. 
1988; Grant and Phillips 1998; Phillips 1999). Natural bentonites (rich in 
montmorillonite) are the common additives used for this purpose. The proposed 
mechanism for which montmorillonite reduces AF bioavailability is by adsorbing the 
molecule into the different clay surfaces (i.e. external, edges and interlayer spaces), 
being the interlayer space the most important site. As a consequence of the pioneering 
studies mentioned above, a variety of materials labeled as mycotoxin binders for use in 
feeds have been introduced in the market, many of them without detailed effectiveness 
and safety studies. Thus, the first objective in the present study was to elucidate the 
mineral characteristics, potential safety and AFB1 adsorption capacities of edible clays 
marketed in Mexico and other countries as AF binders for inclusion in animal feeds. The 
commercial clays were compared to NSP, a montmorillonite rich calcium bentonite that 
has been extensively used as positive control for AF adsorption in many studies. 
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According to the AF sorption analyses, NovaSil, Mycoad, Milbond and Volclay showed 
the best sorption characteristics (i.e. L-shape sorption pattern at pH 2 and 6.5 and Qmax 
values above 0.2 mol kg
-1
). Importantly, the most effective sorbents showed relatively 
higher levels of montmorillonite (according to the relative intensities recorded by XRD) 
when compared to the least effective ones. The differences in AF sorption capacity 
observed for the binders were attributed to the montmorillonite content, particle size 
distribution and/or presence of diluting agents. Regarding potential safety, the 
organoclay-based additives as well as the additive containing yeast cell walls were the 
only ones that induced a toxic response in the hydra assay. This emphasized the need of 
safety studies of organophilic clays that may use quaternary amines of lipids in their 
preparation. The effects of these components on the intestinal micro biota and mucosal 
cells may also be deleterious. The toxicity of yeast derived product was assumed to be 
related to the presence of living yeasts and their growth metabolites. Based on our work, 
the most effective AF-binding additives intended for animal feed had considerable high 
amounts of smectite (i.e., montmorillonite) and this presence of smectite was correlated 
with a favorable L-shape pattern of sorption.   
After the success observed in several animal studies using NS clay to reduce AF 
bioavailability, the application of this technology in humans was of great importance in 
many developing countries with populations at elevated risk. In the Ashanti region in 
Ghana, a population at risk for AFs was identified by measuring AFM1 in the urine and 
AFB1-lysine albumin adducts in the blood. When investigating the cultural habits of this 
population, it was noted that geophagy was prevalent. Edible clays were available in the 
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market place for different intended purposes. Nevertheless, the mineralogy and potential 
AF sorption characteristics of these clays were unknown. Hence, the second objective in 
our study was to investigate the mineral composition, potential AF sorption capacity and 
preliminary safety of edible clays for humans. Geophagic clays from other countries and 
NS were also investigated for comparison purposes. Kaolinite, muscovite and quartz 
were the dominant minerals observed in the majority of the geophagic clays. The 
presence of smectite was evident in several edible clays and its presence was correlated 
with a favorable AF sorption pattern (i.e. L-shape, Langmuir). Nevertheless, most of the 
edible clays had low AF binding capacities (below 0.2 mol kg
-1
) and were regarded as 
ineffective adsorbents for AF. Since none of the clays from Ghana had significant AF 
sorption capacity, NS clay was successfully used in a Phase IIa clinical intervention trial 
conducted in the Ashanti Region of Ghana.  
On the other hand, because NS is derived from naturally-occurring bentonite 
deposits that vary from batch-to-batch in composition, particle size, non-framework 
trace metal content and dioxin levels, an alternative may be more appropriate for long-
term studies in humans. To address this issue and improve consistency and uniformity, 
in this project, we utilized Uniform Particle Size NovaSil (UPSN), a refined material 
selected from NS parent clay that has a more uniform particle size distribution, ideal for 
long-term human application. The selection procedure at which UPSN was subjected 
improved its consistency and uniformity in composition between batches, hence favoring 
its use in clinical trials and as eventual therapy for human aflatoxicosis. As a 
consequence, as part of our third objective, the mineral and AF sorption characteristics 
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of parent NS and UPSN were investigated. Furthermore, since the safety of UPSN was 
unknown, a 3 month rodent study was designed to investigate its effects in vivo. Four-
week-old male and female Sprague Dawley® rats were fed rations free of clay (control) 
and containing UPSN at low dose (0.25%) and high dose (2.0%) levels for 13 weeks. 
Growth parameters such as initial body weight, final body weight, feed conversion 
efficiency, total feed consumption and total body gain weight were determined. Serum 
and blood biochemical parameters were measured along with serum vitamin A and E, 
and iron and zinc. No major differences were noted in the mineral properties and AFB1 
sorption characteristics for both clays. Total body weight gain was unaffected in either 
sex at the doses tested. No UPSN-dependent differences in relative organ weights or 
gross appearance were observed. Isolated differences between UPSN groups and the 
control were observed for some biochemical parameters and selected vitamins and 
minerals. None of these differences were dose-dependent, and all parameters fell 
between ranges reported as normal for rats less than 6 month old. Na, Na/K ratio and 
vitamin E were the only parameters that were increased in both males and females in 
UPSN groups. Zinc levels in males of 2% UPSN group were lower compared to the 
control. Serum K levels were lower in the males of UPSN groups than in the control. 
Importantly, neither Na/K, K, nor Zn values fell outside ranges reported as normal, nor 
apparent dose dependency was observed. These results suggested that dietary inclusion 
of UPSN at levels as high as 2% (w/w) does not result in overt toxicity.  
As the use of smectite clays, mainly Ca-montmorillonite, as strategy to decrease 
bioavailability of AFs became more popular, sustainability issues were apparent and 
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other sources of this material were investigated. According to the major cation present, 
dioctahedral smectites can be regarded as sodium (Na) or calcium (Ca) saturated. Na-
bentonites (mainly composed by montmorillonite) have also been used to prevent AF‟s 
effects on dairy cattle (Diaz et al. 2004), but their potential interactions with other 
additives (Shryock et al. 1994), anticoccidials (Gray et al. 1998) and probable 
interactions with vitamin A (Briggs and Fox, 1956; Laughland and Phillips 1956) have 
been reported. Additionally, earlier investigations have reported incomplete protection 
against AF effects (Voss et al. 1993; Abdel et al. 1999). On the other hand, due to the 
natural origin of this clay, potential contamination with heavy metals and dioxins may 
also be present. Hence, safety and efficacy studies were warranted for this type of clay. 
Our objective five was to elucidate the mineral and AF sorption characteristics of a Na-
bentonite and to determine its safety in a 13 weeks rodent model using Sprague Dawley 
rats. Na-montmorillonite (Na-BENT) was obtained from AMCOL Specialty Minerals 
(Hoffman Estates, IL). Levels of dioxins and selected heavy metals were performed by 
Analytical Perspectives (Wilmington, NC) using US Environmental Protection Agency 
(USEPA) methods. Low levels of both dioxins/furans and the selected heavy metals 
were found in Na-BENT. When the TEQs levels of dioxins/furans (0.081 pg g
-1
) where 
compared to the PTDI (~2.3 pg kg-bw
-1
) values reported by the JECFA, it was 
determined that 3 g of Na-BENT (the intended dose likely to be given to a human 
subject) confer negligible risk of dioxin exposure. Similarly, according to TDI values 
reported by JECFA, the exposure to heavy metals like As, Cd, Hg and Pb from 3 g of 
Na-BENT was minor.  
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In the mineralogical analyses, montmorillonite was confirmed as the main 
ingredient in Na-BENT, according to XRD and FTIR. Na-BENT also contained 
muscovite, quartz, gypsum, calcite and feldspars. The CEC and pH of Na-BENT were 
similar to the values expected for other montmorillonite rich bentonites. In the AF 
adsorption isotherms, the capacity of Na-BENT for AF sorption was also similar to 
observations for other bentonites (Qmax = 0.3 mol kg
-1
). According to this, it is expected 
that Na-BENT may be effective as AF adsorbent in vivo.  
No apparent toxicity effects due to consumption of bentonite at either dose were 
noticed throughout the rodent study. Major findings of the study included 1) the 
increased vitamin E levels observed in both females and males of Na-BENT groups, 2) 
the reduction in serum levels of Zn in the males of Na-BENT groups, 3) the increased 
serum Na and Ca levels in males of Na-BENT groups, and 4) reduction in serum vitamin 
A levels in males of 2% Na-BENT group. Similar results for Na, Ca, Zn and K serum 
levels have been observed in rats ingesting other bentonites (i.e. UPSN) (Marroquin-
Cardona et al. 2011). In the same way, interactions of bentonites with vitamin A have 
also been previously reported in rats ingesting similar clays (Laughland and Phillips 
1954). This may be specific for Na-BENT since other studies using SD rats and 2% 
inclusion in feed of Ca-bentonites have shown no significant changes in serum vitamin 
A levels (Afriyie-Gyawu et al. 2005; Marroquin-Cardona et al. 2011). More research is 
clearly warranted to explain these specific findings.   
In summary, the presence of AFs in feeds seems to be a problem without a clear 
solution. Although there are many strategies to ameliorate the effects of AFs, none of 
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them is solely effective and a multidisciplinary approach must be the best selection. The 
use of clay as potential enterosorbent for AFs is a natural and safe alternative that is also 
cost effective and culturally accepted in some of the countries with the highest risk of 
exposure to AFs. Hopefully in the future, with all the scientific evidence of effectiveness 
and safety that has been accumulated from several animal and human studies, this 
technology can be successfully transferred to populations at risk. Thus contributing to a 
solution for the global health problems associated to AF exposure. 
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